Breaking News Instant updates and real-time market news.

2020-10-13 06:11:10 AAPL Apple $124.29 / +7.3 (+6.24%) 06:11 10/13/20 10/13 06:11 10/13/20 06:11	Only 10% plan to upgrade to Apple's new 5G iPhone, Piper survey shows In a survey of 1,000 Americans, only 10% of respondents expect to buy or upgrade to a new 5G iPhone this fall and winter, Piper Sandler analyst Harsh Kumar tells investors in a research note. In addition, only 10% of current iPhone owners expect to upgrade their device, adds the analyst. Kumar says the results are lower than he expected ahead of the product announcement expected at today's Apple Event and also lower than a prior survey suggesting 23% of current iPhone owners would buy a $1,200 5G iPhone. The survey also points to the average age of an iPhone currently being around 2.3 years old, says the analyst. "We are a bit surprised by the lower than expected demand given the cellular transition, but the global pandemic may be putting pressure on spending patterns this fall/winter," writes Kumar. The analyst keeps an Overweight rating on Apple with a $130 price target.	15 Oct 29 Oct
AAPL Apple $124.29 / +7.3 (+6.24%) 10/12/20 RBC Capital Apple price target raised to $132 from $111 at RBC Capital 10/12/20 Wedbush 'Grand entrance' for Apple's iPhone 12 begins, says Wedbush 10/08/20 Morgan Stanley Morgan Stanley raises iPhone estimates for Apple ahead of launch event 10/07/20 Needham House report on anti-competitive threats unlikely to impact Apple, says Needham

2020-10-13 06:11:10

AAPL

Apple

$124.29 / +7.3 (+6.24%)

06:11

10/13/20

10/13

06:11

10/13/20

06:11

Only 10% plan to upgrade to Apple's new 5G iPhone, Piper survey shows

In a survey of 1,000 Americans, only 10% of respondents expect to buy or upgrade to a new 5G iPhone this fall and winter, Piper Sandler analyst Harsh Kumar tells investors in a research note. In addition, only 10% of current iPhone owners expect to upgrade their device, adds the analyst. Kumar says the results are lower than he expected ahead of the product announcement expected at today's Apple Event and also lower than a prior survey suggesting 23% of current iPhone owners would buy a $1,200 5G iPhone. The survey also points to the average age of an iPhone currently being around 2.3 years old, says the analyst. "We are a bit surprised by the lower than expected demand given the cellular transition, but the global pandemic may be putting pressure on spending patterns this fall/winter," writes Kumar. The analyst keeps an Overweight rating on Apple with a $130 price target.

15
Oct
29
Oct

AAPL Apple

$124.29 / +7.3 (+6.24%)

10/12/20 RBC Capital: Apple price target raised to $132 from $111 at RBC Capital

10/12/20 Wedbush: 'Grand entrance' for Apple's iPhone 12 begins, says Wedbush

10/08/20 Morgan Stanley: Morgan Stanley raises iPhone estimates for Apple ahead of launch event

10/07/20 Needham: House report on anti-competitive threats unlikely to impact Apple, says Needham

TODAY'S FREE FLY STORIES

Periodicals	Pioneer Natural launches sale of assets in Delaware basin of Texas, Reuters says » 18:40 09/17/21 09/17 18:40 09/17/21 18:40 PXD Pioneer Natural $157.03 / +0.04 (+0.03%) Pioneer Natural Resources… Pioneer Natural Resources has put its assets in the Delaware basin of Texas up for sale, looking to secure more than $2B for the properties, Reuters' Arathy Nair, David French, and Shariq Khan report, citing two sources familiar with the matter. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 08/16/21 Omega Advisors buys Bausch Health, exits Comcast Class A in Q2 08/02/21 Pioneer Natural sees Q3 oil production 380-395 MBOPD 05/04/21 Pioneer Natural sees FY21 oil production 351-366 MBOPD 05/04/21 Pioneer Natural sees Q2 oil production 352-367 MBOPD PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 09/09/21 Fly Intel: Top five analyst upgrades 09/09/21 Goldman Sachs Pioneer Natural upgraded to Conviction Buy from Buy at Goldman Sachs 07/22/21 Piper Sandler Pioneer Natural price target raised to $218 from $216 at Piper Sandler 07/15/21 Mizuho Pioneer Natural price target raised to $231 from $224 at Mizuho PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 08/02/21 Pioneer Natural reports Q2 adjusted EPS $2.55, consensus $2.61 05/04/21 Pioneer Natural reports Q1 adjusted EPS $1.77, consensus $1.45 11 May PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 04/01/21 Pioneer Natural near deal to acquire DoublePoint Energy for $6B, Reuters says PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 06/21/21 Wall Street in Fives - Must Read Lists for Monday 06/21/21 Wall Street in Fives - Must Read Lists at Midday 04/05/21 Fly Intel: Pre-market Movers 12/01/21 NASH 2021: Stephens Annual Investment Conference PXD Pioneer Natural $157.03 / +0.04 (+0.03%) 08/19/21 Pioneer Natural call volume above normal and directionally bullish 07/26/21 Pioneer Natural put volume heavy and directionally bearish 06/10/21 Unusually active option classes on open June 10th 06/01/21 Early notable gainers among liquid option names on June 1st
Hot Stocks	Astellas Pharma, Pfizer: XTANDI improved OS in Phase 3 ARCHES study » 18:09 09/17/21 09/17 18:09 09/17/21 18:09 ALPMY Astellas Pharma $17.08 / -0.14 (-0.81%) , PFE Pfizer $43.89 / -0.57 (-1.28%) Astellas Pharma (ALPMY)… Astellas Pharma (ALPMY) and Pfizer (PFE) announced ahead of the European Society for Medical Oncology Congress 2021 that XTANDI improved overall survival in the ARCHES study in men with metastatic hormone-sensitive prostate cancer. The Phase 3, randomized, double-blind, placebo-controlled trial compared XTANDI plus androgen deprivation therapy versus placebo plus ADT in men with mHSPC and OS was a key secondary endpoint. In the study, XTANDI plus ADT reduced the risk of death by 34% compared to placebo plus ADT. Median OS, which represents the time from randomization to death due to any cause, was not reached in either treatment group. The safety profile in both study arms was consistent with findings from the primary analysis. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE ALPMY PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel also recommends Pfizer booster for people with job exposure risk 09/17/21 FDA panel votes 18-0 for EUA for Pfizer booster for people 65+ 09/17/21 FDA panel votes in favor of recommending Pfizer booster for people aged 65+ 09/17/21 Pfizer, Moderna lower after panel votes on booster recommendation ALPMY Astellas Pharma $17.08 / -0.14 (-0.81%) 09/14/21 Astellas Pharma reports passing of ASPIRO clinical trial participant 09/01/21 Astellas Pharma pauses screening, dosing of patients in ASPIRO clinical trial 08/19/21 Astellas, FibroGen get EC approval for Evrenzo in adult CKD patients 07/20/21 FDA expands indication for Astellas Pharma's PROGRAF ALPMY PFE ALPMY Astellas Pharma $17.08 / -0.14 (-0.81%) 06/29/21 Jefferies Astellas Pharma downgraded to Hold from Buy at Jefferies 10/13/20 JMP Securities Seagen price target raised to $216 from $200 at JMP Securities PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Evercore ISI Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters 09/16/21 Canaccord Exact Sciences salesforce expansion a net positive, says Canaccord 09/16/21 BofA Moderna boosters already reflected in 'bullish' consensus, says BofA 09/15/21 Raymond James Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James PFE PFE Pfizer $43.89 / -0.57 (-1.28%) 07/28/21 Pfizer raises FY21 adjusted EPS view to $3.95-$4.05 from $3.55-$3.65 07/28/21 Pfizer reports Q2 adjusted EPS $1.07, consensus 96c 07/27/21 Notable companies reporting before tomorrow's open PFE PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel plans earlier than scheduled vote on Pfizer booster, Bloomberg says 09/17/21 U.S. buying hundreds of millions more Pfizer vaccine to donate, WaPo reports 09/17/21 FDA panel to review data on Covid booster shots, WSJ reports 09/16/21 Moderna's Hoge tells CNBC Delta variant has exposed vaccine weaknesses PFE PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Wall Street in Fives - Must Read Lists for Friday 09/16/21 Wall Street in Fives - Must Read Lists for Thursday 09/16/21 Wall Street in Fives - Must Read Lists at Midday 09/15/21 Wall Street in Fives - Must Read Lists for Wednesday 09/27/21 Global Healthcare Virtual Conference 09/17/21 Vaccines and Related Biological Products Advisory Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 05/06/22 PDUFA Date for MYFEMBREE 09/24/21 Pfizer PFE PFE Pfizer $43.89 / -0.57 (-1.28%) 09/14/21 Pfizer put buyer realizes 95% same-day gains 08/24/21 Notable open interest changes for August 24th 08/23/21 Unusually active option classes on open August 23rd 08/19/21 Notable open interest changes for August 19th
Hot Stocks	Crocs director Bickley sells 5,000 common shares » 17:52 09/17/21 09/17 17:52 09/17/21 17:52 CROX Crocs $155.31 / -2.39 (-1.52%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CROX Crocs $155.31 / -2.39 (-1.52%) 09/14/21 Crocs announces new Accelerated Share Repurchase plan 09/14/21 Crocs up 12% to $154.31 as 2026 'ambition' discussed at investor day 07/22/21 Crocs jumps over 9% to $131.14 per share after Q2 earnings beat, raised guidance 07/22/21 Crocs sues Walmart, Hobby Lobby, others, claiming trademark infringement CROX Crocs $155.31 / -2.39 (-1.52%) 09/15/21 Monness Crespi Crocs price target raised to $180 from $160 at Monness Crespi 09/15/21 B. Riley Crocs price target raised to $174 from $152 at B. Riley 09/15/21 Baird Crocs price target raised to $215 from $160 at Baird 09/15/21 Loop Capital Crocs price target raised to $180 from $150 at Loop Capital CROX Crocs $155.31 / -2.39 (-1.52%) 09/14/21 Crocs reiterates FY21 guidance provided in July 09/14/21 Crocs sees revenues to grow to over $5B by 2026 07/22/21 Crocs sees FY21 revenue growth 60%-65%, consensus $2.04B 07/22/21 Crocs sees Q3 revenue growth 60%-70%, consensus $506.61M CROX Crocs $155.31 / -2.39 (-1.52%) 05/01/21 Crocs looks primed for a reopening, Barron's says CROX Crocs $155.31 / -2.39 (-1.52%) 09/14/21 Wall Street in Fives - Must Read Lists for Tuesday 07/22/21 Wall Street in Fives - Must Read Lists at Midday 05/26/21 Fly Intel: After-Hours Movers 04/27/21 Fly Intel: Wall Street's top stories for Tuesday CROX Crocs $155.31 / -2.39 (-1.52%) 09/15/21 Crocs call volume above normal and directionally bullish 09/15/21 Unusually active option classes on open September 15th 05/19/21 Crocs put volume heavy and directionally bearish
Hot Stocks	NTSB to conduct safety investigation of fatal Tesla Model 3 crash in Florida » 17:48 09/17/21 09/17 17:48 09/17/21 17:48 TSLA Tesla $759.92 / +2.995 (+0.40%) The NTSB said that, in… The NTSB said that, in coordination with City of Coral Gables Police Department, it is sending three investigators to conduct a safety investigation of the fatal Sept. 13, 2021, vehicle crash involving a Tesla Model 3 that departed the roadway and collided with a tree in Coral Gables, Florida. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSLA Tesla $759.92 / +2.995 (+0.40%) 09/16/21 Lucid says Air Dream Edition R longest-range EV ever rated by EPA at 520 miles 09/16/21 EU passenger car registrations down 19.1% in August 09/15/21 Rivian CEO: First customer vehicle drove off production line on Tuesday 09/09/21 Tesla CEO Musk says FSD 10 'will blow your mind' TSLA Tesla $759.92 / +2.995 (+0.40%) 09:23 Today Morgan Stanley 520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley 07:35 Today Wedbush Tesla EV demand story just starting to play out, says Wedbush 09/15/21 BofA BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy 09/10/21 Craig-Hallum VIA Optronics price target lowered to $14 from $18 at Craig-Hallum TSLA Tesla $759.92 / +2.995 (+0.40%) 07/30/21 Musk sides with Epic, says Apple fees 'de facto global tax' on internet 07/26/21 Tesla reports Q2 non-GAAP EPS $1.45, consensus 96c 07/26/21 Notable companies reporting after market close 04/26/21 Tesla reports Q1 non-GAAP EPS 93c, consensus 79c TSLA Tesla $759.92 / +2.995 (+0.40%) 09/13/21 MIT study shows Tesla Autopilot leads to lower driver attention, Electrek says 09/09/21 Tesla aims for 'decent' quarter for deliveries with a strong end, Electrek says 09/07/21 Toyota to spend $13.6B in battery development and supply, FT reports 09/03/21 NHTSA probing Tesla crash that killed man changing tire, AP reports TSLA Tesla $759.92 / +2.995 (+0.40%) 09:40 Today Take-Two downgrade among today's top calls on Wall Street 09/13/21 Charged: Tesla's FSD wider release expected this month 09/10/21 Wall Street in Fives - Must Read Lists at Midday 09/07/21 Charged: SEC opens probe into Workhorse, Tesla pushes back Cybertruck timeline 10/07/21 Tesla, Inc. TSLA Tesla $759.92 / +2.995 (+0.40%) 08:55 Today Notable open interest changes for September 17th 09/16/21 Notable open interest changes for September 16th 09/15/21 Notable open interest changes for September 15th 09/14/21 Notable open interest changes for September 14th
Conference/Events	Angion Biomedica to host research and development virtual day » 17:38 09/17/21 09/17 17:38 09/17/21 17:38 ANGN Angion Biomedica $10.57 / -0.38 (-3.47%) Research and Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ANGN Angion Biomedica $10.57 / -0.38 (-3.47%) 06/29/21 Angion Biomedica ALI-201 trial did not meet primary, secondary endpoints 06/29/21 Angion Biomedica ALI-201 trial did not meet primary, secondary endpoints 05/17/21 Angion Biomedica expects cash to fund planned operations into 2022 05/17/21 Angion Biomedica announces upcoming milestones ANGN Angion Biomedica $10.57 / -0.38 (-3.47%) 03/02/21 Fly Intel: Top five analyst initiations 03/02/21 Cowen Angion Biomedica initiated with an Outperform at Cowen 03/02/21 Oppenheimer Angion Biomedica initiated with an Outperform at Oppenheimer 03/02/21 Stifel Angion Biomedica initiated with a Buy at Stifel ANGN Angion Biomedica $10.57 / -0.38 (-3.47%) 08/12/21 Angion Biomedica reports Q2 EPS (58c), consensus (69c) 05/17/21 Angion Biomedica reports Q1 EPS ($1.56), consensus (61c) 03/30/21 Angion Biomedica reports Q4 EPS ($1.90), consensus ($1.30) 05 Feb ANGN Angion Biomedica $10.57 / -0.38 (-3.47%) 06/29/21 Fly Intel: After-Hours Movers 09/21/21 Fall Healthcare Life Sciences & MedTech Summit

Hot Stocks	Azek exec Ochoa sells 20,000 class A shares » 17:37 09/17/21 09/17 17:37 09/17/21 17:37 AZEK Azek $38.56 / +0.495 (+1.30%) In a regulatory filing,… In a regulatory filing, Azek Residential Segment President Joe Ochoa disclosed the sale of 20,000 class A common shares of the company on September 17 at a price of $38.67 per share. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AZEK Azek $38.56 / +0.495 (+1.30%) 09/03/21 Azek CEO sells 90,000 class A common shares 08/12/21 Azek rises 9.7% 07/19/21 Azek names Peter Clifford as new CFO 06/17/21 Azek CEO: We're very bullish about our future AZEK Azek $38.56 / +0.495 (+1.30%) 05/14/21 Baird Azek price weakness a buying opportunity, says Baird 05/05/21 JPMorgan Azek initiated with a Neutral at JPMorgan 04/13/21 Wedbush Wedbush starts Azek with Outperform, $52 price target 04/12/21 Wedbush Azek initiated with an Outperform at Wedbush AZEK Azek $38.56 / +0.495 (+1.30%) 08/12/21 Azek raises FY21 revenue view to up 28%-30% from up 10%-14%, consensus $1.12B 08/12/21 Azek reports Q3 adjusted EPS 21c, consensus 23c 05/13/21 Azek raises FY21 revenue view to up 23%-26% from 10%-14%, consensus $1.05B 05/13/21 Azek sees Q3 revenue up 29%-32%, consensus $275.49M 27 May 22 Jan AZEK Azek $38.56 / +0.495 (+1.30%) 05/24/21 Fly Intel: After-Hours Movers 12/01/21 NASH 2021: Stephens Annual Investment Conference
Syndicate	Greenidge Generation files to sell 3.5M shares of Class A common for holders 17:35 09/17/21 09/17 17:35 09/17/21 17:35 GREE Greenidge Generation $39.25 / -4.35 (-9.98%)
Hot Stocks	Rolls-Royce awarded $194M Army contract » 17:17 09/17/21 09/17 17:17 09/17/21 17:17 RYCEY Rolls-Royce $1.49 / +0.02 (+1.36%) Rolls-Royce was awarded a… Rolls-Royce was awarded a $194M firm-fixed-price contract for the acquisition of Namer Armored Personnel Carrier Power Packs Less Transmissions. Bids were solicited via the internet with one received. Work will be performed in Novi, Michigan, with an estimated completion date of December 31. FY20 Foreign Military Sales funds in the amount of $194M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity. ShowHide Related Items >><< Company News Street Research Periodicals On The Fly RYCEY Rolls-Royce $1.49 / +0.02 (+1.36%) 08/16/21 Bombardier further expands engine maintenance offering 08/04/21 Rolls-Royce confirms exclusive talks with consortium regarding ITP Aero sale 07/13/21 AerCap leases seven Airbus A350 aircraft to Delta Air Lines 06/30/21 Shell, Rolls-Royce sign MoU to support decarbonization of aviation industry RYCEY Rolls-Royce $1.49 / +0.02 (+1.36%) 08/17/21 JPMorgan Rolls-Royce price target raised to 130 GBp from 105 GBp at JPMorgan 08/09/21 Deutsche Bank Rolls-Royce price target raised to 116 GBp from 113 GBp at Deutsche Bank 08/06/21 Societe Generale Rolls-Royce price target raised to 100 GBp from 95 GBp at Societe Generale 07/09/21 Jefferies Rolls-Royce coverage transferred at Jefferies RYCEY Rolls-Royce $1.49 / +0.02 (+1.36%) 08/30/21 Causeway Capital calls for board 'refresh' at Rolls-Royce, FT reports RYCEY Rolls-Royce $1.49 / +0.02 (+1.36%) 06/13/21 On the Fly: The Week in SPAC News
Hot Stocks	Abbott awarded $119.51M Defense Logistics Agency contract » 17:14 09/17/21 09/17 17:14 09/17/21 17:14 ABT Abbott $126.80 / -0.65 (-0.51%) Abbott was awarded a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABT Abbott $126.80 / -0.65 (-0.51%) 11:37 Today FDA warning on potential for false positives with Abbott Alinity COVID test 09/02/21 Abbott announces acquisition of Walk Vascular 08/30/21 Abbott says Amulet superior to Boston Scientific's Watchman in stroke study 08/27/21 Abbott announces results from GUIDE-HF clinical trial ABT Abbott $126.80 / -0.65 (-0.51%) 13:19 Today Raymond James U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James 08/31/21 BTIG Abbott price target raised to $136 from $126 at BTIG 08/31/21 Barclays Abbott's Amulet could become 'needle mover,' says Barclays 08/30/21 Piper Sandler Boston Scientific's Watchman still well positioned, says Piper Sandler ABT Abbott $126.80 / -0.65 (-0.51%) 08/10/21 Cardinal Health partners with Abbott and Quidel to distribute COVID-19 tests 07/22/21 Abbott sees Q3 adjusted EPS 'at least' 90c, consensus 98c 07/22/21 Abbott backs FY21 adjusted EPS view $4.30-$4.50, consensus $4.36 07/22/21 Abbott reports Q2 adjusted EPS $1.17, consensus $1.02 ABT Abbott $126.80 / -0.65 (-0.51%) 08/26/21 CVS limiting sale of Abbott Covid test, Bloomberg reports 08/23/21 At-home Covid tests leave many cases uncounted, Bloomberg reports 08/20/21 Abbott scrambles to meet test demand after layoffs and inventory purge, NYT says 05/04/21 Glucose monitor gaining traction in sports, tech groups, WSJ reports ABT Abbott $126.80 / -0.65 (-0.51%) 09/13/21 Fly Insider: Asana, Autodesk among week's notable insider trades 06/01/21 Wall Street in Fives - Must Read Lists for Tuesday 06/01/21 Wall Street in Fives - Must Read Lists at Midday 06/01/21 Fly Intel: Pre-market Movers 11/08/21 PPharma Marketing USA ABT Abbott $126.80 / -0.65 (-0.51%) 07/19/21 Early notable gainers among liquid option names on July 19th 06/18/21 Abbott put volume heavy and directionally bearish 06/02/21 Unusually active option classes on open June 2nd 04/20/21 Unusually active option classes on open April 20th
Hot Stocks	Quidel awarded $710.57M Defense Logistics Agency contract » 17:12 09/17/21 09/17 17:12 09/17/21 17:12 QDEL Quidel $153.43 / +8.93 (+6.18%) Quidel has been awarded a… Quidel has been awarded a maximum $710.57M indefinite-delivery/indefinite-quantity contract for over-the-counter antigen test kits. This was a competitive acquisition with three responses received. This is a one-year contract with no option periods. Location of performance is all 50 states, with a September 14, 2022, ordering period end date. Primary customer is the Department of Health and Human Services. Type of appropriation is FY21 through FY22 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly QDEL Quidel $153.43 / +8.93 (+6.18%) 09/01/21 Quidel to bring QuickVue At-Home OTC COVID-19 Tests to CVS pharmacies 07/26/21 Quidel resolves litigation with Beckman Coulter 07/26/21 Beckman Coulter to distribute BNP cardiac assay to customers 07/19/21 Quidel not commenting on report claiming OraSure rejected takeover approach QDEL Quidel $153.43 / +8.93 (+6.18%) 13:19 Today Raymond James U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James 07/26/21 Piper Sandler Quidel agreement with Beckman removes overhang, says Piper Sandler 07/19/21 Raymond James Quidel contract with Delaware could increase materially, says Raymond James 07/19/21 Raymond James Quidel contact with Delaware could increase materially, says Raymond James QDEL Quidel $153.43 / +8.93 (+6.18%) 08/10/21 Cardinal Health partners with Abbott and Quidel to distribute COVID-19 tests 08/05/21 Quidel reports Q2 adjusted EPS 75c, consensus $1.46 05/06/21 Quidel reports Q1 adjusted EPS $4.38, consensus $4.71 04/22/21 Quidel sees Q1 revenue $374M-$376M, consensus $465.7M QDEL Quidel $153.43 / +8.93 (+6.18%) 08/23/21 At-home Covid tests leave many cases uncounted, Bloomberg reports QDEL Quidel $153.43 / +8.93 (+6.18%) 04/22/21 Fly Intel: After-Hours Movers

Hot Stocks	Boeing awarded $1.62B Navy contract » 17:10 09/17/21 09/17 17:10 09/17/21 17:10 BA Boeing $213.37 / +0.05 (+0.02%) Boeing has been awarded a… Boeing has been awarded a $1.62B indefinite-delivery/indefinite-quantity contract for missile guidance repair. This contract will repair the Minuteman III Intercontinental Ballistic Missile, or ICBM, missile guidance set. Work will be performed in Newark, Ohio, and is expected to be completed by September 27, 2039. This award is the result of a sole-source acquisition. FY21 operation and maintenance funds in the amount of $32.49M are being obligated at the time of award. The Air Force Nuclear Weapons Center is the contracting activity. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BA Boeing $213.37 / +0.05 (+0.02%) 09/16/21 Boeing appoints Ziad Ojakli as EVP, government operations 09/14/21 Boeing sees demand for over 2.1M aviation personnel over next 20 years 09/14/21 Boeing sees $2.6T defense and space market opportunity through 2030 09/14/21 Boeing sees $3.2T market opportunity for its served services market through 2030 BA Boeing $213.37 / +0.05 (+0.02%) 09/15/21 Susquehanna Boeing upcoming catalysts should move shares higher, says Susquehanna 09/07/21 UBS Boeing price target lowered to $290 from $310 at UBS 09/07/21 Baird Boeing delivery expectations may be too high, says Baird 09/01/21 Susquehanna Boeing delivery estimates lowered due to continued suspension, says Susquehanna BA Boeing $213.37 / +0.05 (+0.02%) 07/28/21 Boeing reports Q2 core EPS 40c, consensus (72c) 07/27/21 Notable companies reporting before tomorrow's open 04/28/21 Boeing reports Q1 core EPS ($1.53), consensus ($1.16) BA Boeing $213.37 / +0.05 (+0.02%) 09/17/21 Former Boeing pilot could face prosection in 787 MAX investigation, WSJ reports 09/08/21 Boeing investors may pursue 737 MAX claims against board, Reuters reports 09/06/21 Big Boeing customer walking away from new MAX order, WSJ reports 09/05/21 Boeing Dreamliners delivery likely halted until at least October, WSJ says BA Boeing $213.37 / +0.05 (+0.02%) 09/15/21 Chevron downgrade among today's top calls on Wall Street 09/07/21 Wall Street in Fives - Must Read Lists for Tuesday 09/07/21 Wall Street in Fives - Must Read Lists at Midday 09/07/21 Fly Intel: Pre-market Movers BA Boeing $213.37 / +0.05 (+0.02%) 08/12/21 Unusually active option classes on open August 12th 08/04/21 Boeing call volume above normal and directionally bullish 07/28/21 Early notable gainers among liquid option names on July 28th 07/28/21 Unusually active option classes on open July 28th
Hot Stocks	Oscar Health CEO acquires 57,300 class A shares » 17:08 09/17/21 09/17 17:08 09/17/21 17:08 OSCR Oscar Health $17.50 / +0.02 (+0.11%) In a regulatory filing,… In a regulatory filing, Oscar Health CEO Mario Schlosser disclosed the purchase of 57,300 class A common shares of the company on September 16 at a price of $17.5308 per share. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly OSCR Oscar Health $17.50 / +0.02 (+0.11%) 09/07/21 Oscar Health co-founder buys $8.77M in common stock 09/02/21 Oscar Health rallies after Thrive Partners buys $9.53M more of shares 08/25/21 Oscar Health rises 4.8% 08/16/21 Oscar Health falls -11.4% OSCR Oscar Health $17.50 / +0.02 (+0.11%) 09/09/21 Cowen Oscar Health initiated with a Market Perform at Cowen 08/04/21 Morgan Stanley Morgan Stanley upgrades Bright Health to Overweight following underperformance 03/29/21 Wells Fargo Oscar Health initiated with an Overweight at Wells Fargo 03/29/21 Fly Intel: Top five analyst initiations OSCR Oscar Health $17.50 / +0.02 (+0.11%) 08/12/21 Oscar Health reports Q2 EPS (35c), consensus (46c) 05/13/21 Oscar Health reports Q1 adjusted EBITDA ($26.3M) vs. ($86.2M) last year 03 Mar OSCR Oscar Health $17.50 / +0.02 (+0.11%) 08/12/21 Fly Intel: After-Hours Movers
Syndicate	PBF Logistics files automatic mixed securities shelf 17:07 09/17/21 09/17 17:07 09/17/21 17:07 PBFX PBF Logistics $12.20 / -0.17 (-1.37%) ShowHide Related Items >><< Street Research Earnings Events PBFX PBF Logistics $12.20 / -0.17 (-1.37%) 07/29/21 R.F. Lafferty PBF Logistics price target lowered to $16 after earnings at R.F. Lafferty 02/17/21 Citi PBF Logistics price target raised to $12 from $8.50 at Citi PBFX PBF Logistics $12.20 / -0.17 (-1.37%) 07/29/21 PBF Logistics reports Q2 EPS 59c, consensus 54c 10/28/21 PBF Logistics - PBFX
Syndicate	Humacyte files to sell 90.07M shares of common stock for holders 17:02 09/17/21 09/17 17:02 09/17/21 17:02 HUMA Humacyte $14.25 / +0.09 (+0.64%) ShowHide Related Items >><< Company News Street Research Options HUMA Humacyte $14.25 / +0.09 (+0.64%) 08/30/21 Fresenius Medical Care investing additional $25M in Humacyte 08/24/21 Alpha Healthcare reports investor approval of combination with Humacyte HUMA Humacyte $14.25 / +0.09 (+0.64%) 09/16/21 Fly Intel: Top five analyst initiations 09/16/21 Piper Sandler Humacyte initiated with an Overweight at Piper Sandler 04/09/21 Lake Street Lake Street starts Alpha Healthcare Acquisition at Buy ahead of Humacyte closing HUMA Humacyte $14.25 / +0.09 (+0.64%) 08/31/21 Largest borrow rate increases among liquid names 08/27/21 Six new option listings and seven option delistings on August 27th
Syndicate	Alkaline Water files to sell 9.51M shares of common stock for holders 17:01 09/17/21 09/17 17:01 09/17/21 17:01 WTER Alkaline Water $1.63 / +0.045 (+2.84%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WTER Alkaline Water $1.63 / +0.045 (+2.84%) 07/30/21 Alkaline Water announces Tom Hutchison as CMO 07/02/21 Alkaline Water postpones earnings call after filing NT 10-K earlier this week 05/26/21 Alkaline Water announces Caribbean distribution partnership with SaluVid 05/18/21 Alkaline Water renews partnership with Barstool Sports WTER Alkaline Water $1.63 / +0.045 (+2.84%) 07/07/21 Fly Intel: Top five analyst downgrades 07/07/21 Canaccord Canaccord downgrades Alkaline Water to Sell, says rally overdone 07/06/21 Canaccord Alkaline Water downgraded to Sell from Hold at Canaccord WTER Alkaline Water $1.63 / +0.045 (+2.84%) 07/06/21 Alkaline Water sees FY22 revenue up 35% to $62M 07/06/21 Alkaline Water reports FY21 revenue up 20% to $46M 07/02/21 Alkaline Water postpones FY21 earnings release WTER Alkaline Water $1.63 / +0.045 (+2.84%) 07/06/21 Wall Street in Fives - Must Read Lists for Tuesday 07/06/21 Wall Street in Fives - Must Read Lists at Midday 07/02/21 Wall Street in Fives - Must Read Lists for Friday 07/02/21 Wall Street in Fives - Must Read Lists at Midday 09/29/21 The Alkaline Water Company Inc.

Syndicate	ShiftPixy files to sell 15.42M shares of common stock for holders 16:50 09/17/21 09/17 16:50 09/17/21 16:50 PIXY ShiftPixy $1.24 / -0.02 (-1.59%) ShowHide Related Items >><< Company News Options PIXY ShiftPixy $1.24 / -0.02 (-1.59%) 09/15/21 ShiftPixy Labs teases 'something big' coming in tweet 04/15/21 ShiftPixy teases Friday announcement PIXY ShiftPixy $1.24 / -0.02 (-1.59%) 08/04/21 Largest borrow rate increases among liquid names 08/02/21 Largest borrow rate increases among liquid names 07/21/21 Largest borrow rate increases among liquid names 07/15/21 ShiftPixy options imply 20.7% move in share price post-earnings
Hot Stocks	Olympic Steel announces sale of Detroit assets for $58.4M » 16:44 09/17/21 09/17 16:44 09/17/21 16:44 ZEUS Olympic Steel $24.51 / -0.35 (-1.41%) Olympic Steel announced… Olympic Steel announced the sale of substantially all of the company's Detroit assets and operations to Venture Steel. The sale price, which exceeded the book value of the net assets sold, was $58.4M in cash, subject to a future working capital adjustment, which is expected to increase the final sale price. ShowHide Related Items >><< Earnings ZEUS Olympic Steel $24.51 / -0.35 (-1.41%) 08/05/21 Olympic Steel reports Q2 EPS $2.58, consensus $1.88 05/07/21 Olympic Steel reports Q1 adjusted EPS $1.97, consensus $1.29
Syndicate	High Tide files $100M mixed securities shelf 16:41 09/17/21 09/17 16:41 09/17/21 16:41 HITI High Tide $6.81 / +0.24 (+3.65%) ShowHide Related Items >><< Company News Street Research Options HITI High Tide $6.81 / +0.24 (+3.65%) 09/13/21 High Tide enters while label partnerships with Heritage Cannabis, Loosh 08/31/21 High Tide expands into Durham Region in Ontario 07/20/21 High Tide subsidiary High Tide USA acquires online retailer DankStop for $3.85M 07/20/21 High Tide to acquire DankStop for $3.85M, sees accretion HITI High Tide $6.81 / +0.24 (+3.65%) 09/13/21 Roth Capital High Tide initiated with a Buy rating at Roth Capital 09/02/21 Desjardins High Tide initiated with a Buy at Desjardins HITI High Tide $6.81 / +0.24 (+3.65%) 06/09/21 Four new option listings on June 9th
Hot Stocks	FDA panel also recommends Pfizer booster for people with job exposure risk » 16:40 09/17/21 09/17 16:40 09/17/21 16:40 PFE Pfizer $43.89 / -0.57 (-1.28%) , BNTX BioNTech $358.75 / -13.75 (-3.69%) , MRNA Moderna $429.30 / -11.54 (-2.62%) According to CNBC's… According to CNBC's Meg Tirrell, an FDA panel voted 18 "yes" to zero "no" to include healthcare workers or others at high risk for occupation exposure to be included in the Pfizer booster EUA. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel votes 18-0 for EUA for Pfizer booster for people 65+ 09/17/21 FDA panel votes in favor of recommending Pfizer booster for people aged 65+ 09/17/21 Pfizer, Moderna lower after panel votes on booster recommendation 09/17/21 FDA panel votes against recommending booster dose of Pfizer COVID vaccine PFE BNTX MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Evercore ISI Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters 09/16/21 Canaccord Exact Sciences salesforce expansion a net positive, says Canaccord 09/16/21 BofA Moderna boosters already reflected in 'bullish' consensus, says BofA 09/15/21 Raymond James Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/27/21 UBS BioNTech price target raised to $300 from $111 at UBS 08/20/21 Canaccord BioNTech price target raised to $450 from $240 at Canaccord 08/12/21 Wells Fargo Wells says Moderna vaccine looks more effective than Pfizer's against Delta MRNA Moderna $429.30 / -11.54 (-2.62%) 08/06/21 Fly Intel: Top five analyst downgrades PFE MRNA BNTX PFE Pfizer $43.89 / -0.57 (-1.28%) 07/28/21 Pfizer raises FY21 adjusted EPS view to $3.95-$4.05 from $3.55-$3.65 07/28/21 Pfizer reports Q2 adjusted EPS $1.07, consensus 96c 07/27/21 Notable companies reporting before tomorrow's open MRNA Moderna $429.30 / -11.54 (-2.62%) 08/05/21 Moderna reports Q2 EPS $6.46, consensus $6.04 08/04/21 Notable companies reporting before tomorrow's open 05/06/21 Moderna reports Q1 EPS $2.84, consensus $2.39 BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/09/21 BioNTech sees 2021 capex EUR 175M - EUR 225M 08/09/21 BioNTech reports Q2 EPS EUR 10.77 vs. (EUR 0.38) last year 05/10/21 BioNTech reports Q1 EPS EUR 4.39 vs. (EUR 0.24) last year PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel plans earlier than scheduled vote on Pfizer booster, Bloomberg says 09/17/21 U.S. buying hundreds of millions more Pfizer vaccine to donate, WaPo reports 09/17/21 FDA panel to review data on Covid booster shots, WSJ reports 09/16/21 Moderna's Hoge tells CNBC Delta variant has exposed vaccine weaknesses MRNA Moderna $429.30 / -11.54 (-2.62%) 09/13/21 Pfizer shot could be authorized for children age 5-11 in October, Reuters report 09/09/21 Biden to ask Labor Department for employer vaccine rule, NBC reports PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Wall Street in Fives - Must Read Lists for Friday 09/16/21 Wall Street in Fives - Must Read Lists for Thursday 09/16/21 Wall Street in Fives - Must Read Lists at Midday 09/15/21 Wall Street in Fives - Must Read Lists for Wednesday MRNA Moderna $429.30 / -11.54 (-2.62%) 09/15/21 Fly Intel: After-Hours Movers 09/09/21 Wall Street in Fives - Must Read Lists for Thursday 09/27/21 Global Healthcare Virtual Conference 11/09/21 BioNTech - BNTX 09/17/21 Vaccines and Related Biological Products Advisory Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 05/06/22 PDUFA Date for MYFEMBREE 09/24/21 Pfizer PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/14/21 Pfizer put buyer realizes 95% same-day gains 08/24/21 Notable open interest changes for August 24th 08/23/21 Unusually active option classes on open August 23rd 08/19/21 Notable open interest changes for August 19th MRNA Moderna $429.30 / -11.54 (-2.62%) 09/16/21 Early notable gainers among liquid option names on September 16th 09/09/21 Early notable gainers among liquid option names on September 9th 08/31/21 Early notable gainers among liquid option names on August 31st 08/25/21 Early notable gainers among liquid option names on August 25th
On The Fly	Wall Street in Fives - Must Read Lists for Friday » 16:34 09/17/21 09/17 16:34 09/17/21 16:34 TMO Thermo Fisher $596.98 / +36.11 (+6.44%) , FANG Diamondback Energy $82.56 / +2.43 (+3.03%) , X U.S. Steel $23.36 / -2.03 (-8.00%) , AMC AMC Entertainment $44.23 / -1.82 (-3.95%) , $ETH Ethereum / + , $BTC Bitcoin / + , BTC Bitcoin / + , BITCOIN Bitcoin / + , $LTC Litecoin / + , TTWO Take-Two $151.79 / -0.1 (-0.07%) , ACCD Accolade $45.35 / +0.35 (+0.78%) , LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) , WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) , FIVN Five9 $175.22 / +7.19 (+4.28%) , ZM Zoom Video $287.58 / +9.63 (+3.46%) , IVZ Invesco $26.25 / +1.37 (+5.51%) , STT State Street $84.81 / -2.195 (-2.52%) , ZYME Zymeworks $35.62 / -0.435 (-1.21%) , UL Unilever $53.95 / -0.585 (-1.07%) , WFC Wells Fargo $46.46 / +0.17 (+0.37%) , DB Deutsche Bank $12.91 / -0.21 (-1.60%) , NOG Northern Oil and Gas $17.32 / -1.12 (-6.07%) , CRK Comstock Resources $8.66 / -0.2 (-2.26%) , IPHA Innate Pharma $8.07 / +2.31 (+40.10%) , AZN AstraZeneca $55.56 / -1.04 (-1.84%) , BGNE BeiGene $403.60 / +18.32 (+4.75%) , PTGX Protagonist Therapeutics $17.60 / -28.53 (-61.85%) , TCRR TCR2 Therapeutics $10.00 / -5.715 (-36.38%) , GRTS Gritstone $11.49 / -2.015 (-14.93%) , MANU Manchester United $18.00 / +0.375 (+2.13%) , CNI Canadian National $118.30 / +2.45 (+2.11%) , IFF IFF $135.21 / -7.9 (-5.52%) , PGR Progressive $92.64 / -0.35 (-0.38%) , MCFT MasterCraft Boat $25.60 / +0.03 (+0.12%) , PFE Pfizer $43.89 / -0.57 (-1.28%) , BNTX BioNTech $358.75 / -13.75 (-3.69%) Get caught up quickly on… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYME ZM X WYNN WFC UL TTWO TMO TCRR STT PTGX PGR PFE NOG MCFT MANU LVS IVZ IPHA IFF GRTS FIVN FANG DB CNI BITCOIN BGNE AZN AMC ACCD $LTC $ETH $BTC ZYME Zymeworks $35.62 / -0.435 (-1.21%) 07/28/21 Zymeworks doses first patient in zanidatamab combination study 07/01/21 Zymeworks up 9% as blog report speculates on takeover interest 04/19/21 Zymeworks falls -5.6% 04/19/21 Zymeworks announces Diana Hausman, M.D. transitioning out of CMO role ZM Zoom Video $287.58 / +9.63 (+3.46%) 09/15/21 Zoom Video announces reseller partner program for Zoom Phone BYOC 09/15/21 Cathie Wood's ARK Investment bought 235.6K shares of Zoom Video on Tuesday 09/13/21 Zoom building new Whiteboard experience, working on Facebook VR support 09/01/21 Cathie Wood's ARK Investment bought 194K shares of Zoom Video on Tuesday X U.S. Steel $23.36 / -2.03 (-8.00%) 09/17/21 U.S. Steel falls -4.9% 09/16/21 U.S. Steel says it has reduced debt by roughly $2.7B YTD 09/16/21 U.S. Steel announces site selection process for new $3B mini mill 06/29/21 U.S. Steel executes non-exclusive MOU with Equinor on carbon capture and storage WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) 09/17/21 WynnBET, Indianapolis Colts announce new multi-year partnership 09/14/21 WynnBET named an official sports betting partner of the New York Jets 09/07/21 Genius Sports secures data, NFL, fan engagement partnership with WynnBET WFC Wells Fargo $46.46 / +0.17 (+0.37%) 09/15/21 Wells Fargo announces strategic partnerships with Microsoft, Google Cloud 09/14/21 Wells Fargo 'affirms focus on building strong risk and control foundation' 09/14/21 Wells Fargo CFO: Trajectory of expenses to be 'down' y/y over next few years 09/14/21 Wells Fargo CFO: Could see expenses $53B-$53.5B of FY21 UL Unilever $53.95 / -0.585 (-1.07%) 08/31/21 Tapestry appoints Johanna Hanneke Faber to board of directors 07/19/21 Ben & Jerry's to end ice cream sales in Occupied Palestinian Territory 06/02/21 Arrow Electronics announces Fabian Garcia as new director to board 04/26/21 Unilever acquires lifestyle company Onnit, terms not disclosed TTWO Take-Two $151.79 / -0.1 (-0.07%) 09/14/21 EA's new 'Madden' debuted as best-selling game in August in U.S., says NPD 09/14/21 U.S. video game spending grew 7% y/y in August, says NPD 08/13/21 Nintendo's 'Zelda: Skyward Sword' best-selling game of July, says NPD 08/13/21 Video game hardware spending rose 10% y/y in July, says NPD TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 09/17/21 Thermo Fisher sees FY25 revenue $48.8B-$50.8B 09/17/21 Thermo Fisher sees 2022-2025 EPS CAGR 14%-15% 09/10/21 Thermo Fisher's Oncomine Dx Target Test receives approval by Japan MHLW 09/08/21 Thermo Fisher plans to establish single-use technology manufacturing facility TCRR TCR2 Therapeutics $10.00 / -5.715 (-36.38%) 09/17/21 TCR2 Therapeutics announces interim results from Phase 1/2 trial of Gavo-cel 09/02/21 TCR2 Therapeutics receives orphan drug designation for Gavo-cel 09/02/21 TCR2 Therapeutics gavo-cel gets orphan status in treatment of cholangiocarcinoma 07/20/21 TCR2 Therapeutics appoints Peter Olagunju as CTO STT State Street $84.81 / -2.195 (-2.52%) 09/07/21 State Street to acquire Brown Brothers Harriman Investor Services for $3.5B 09/07/21 State Street to acquire Brown Brothers Harriman Investor Services for $3.5B 07/27/21 State Street files 2021 resolution plan 07/22/21 Janus Henderson Group appoints James Lowry as global COO PTGX Protagonist Therapeutics $17.60 / -28.53 (-61.85%) 09/17/21 Protagonist Therapeutics reports FDA clinical hold on rusfertide program 09/07/21 Protagonist Therapeutics appoints Scott Plevy as Executive VP, Therapeutic Head 08/10/21 Protagonist Therapeutics resolves contract dispute with Zealand Pharma 07/28/21 Protagonist Therapeutics announces amendment of agreement with Janssen Biotech PGR Progressive $92.64 / -0.35 (-0.38%) 07/15/21 Progressive falls -6.4% 05/10/21 Progressive announces dividend, share repurchase authorization 05/02/21 Fly Intel: Top five weekend stock stories PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel votes 18-0 for EUA for Pfizer booster for people 65+ 09/17/21 FDA panel votes in favor of recommending Pfizer booster for people aged 65+ 09/17/21 Pfizer, Moderna lower after panel votes on booster recommendation 09/17/21 FDA panel votes against recommending booster dose of Pfizer COVID vaccine NOG Northern Oil and Gas $17.32 / -1.12 (-6.07%) 08/03/21 Northern Oil and Gas raises quarterly dividend 50% to 4.5c per share 07/29/21 Northern Oil and Gas reports 106% increase in midyear proved reserves 06/16/21 Northern Oil and Gas announces Permian bolt-on acquisitions totaling $102M MCFT MasterCraft Boat $25.60 / +0.03 (+0.12%) 06/28/21 MasterCraft Boat announces up to $50M share repurchase program MANU Manchester United $18.00 / +0.375 (+2.13%) 08/27/21 Manchester United jumps after reaching deal with Juventus for Ronaldo 08/27/21 Manchester United extends rally, up 10% to $19 after Ronaldo signing 08/27/21 Manchester United rallies after confirming deal with Cristiano Ronaldo 08/11/21 Manchester United enters partnership with Ecolab ahead of welcoming back crowds LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 09/16/21 New Jersey reports August gaming revenue up 31.0% to $427.7M 09/15/21 Las Vegas Sands falls -5.6% 09/14/21 Las Vegas Sands falls -13.0% 09/14/21 Las Vegas Sands falls -8.9% IVZ Invesco $26.25 / +1.37 (+5.51%) 09/17/21 Invesco rises 5.8% 09/14/21 Invesco senior managing director Lo sells 150,000 common shares 09/13/21 Invesco reports preliminary AUM $1.56T as of August 31 08/13/21 Nelson Peltz's Trian Fund boosts Janus Henderson, cuts Sysco in Q2 IPHA Innate Pharma $8.07 / +2.31 (+40.10%) 09/17/21 AstraZeneca presents results from COAST Phase 2 trial of monalizumab 07/06/21 Innate Pharma announces FORCE trial did not meet primary endpoints 06/22/21 Innate Pharma presents preliminary data from TELLOMAK trial 06/10/21 Innate Pharma to present latest ANKET preclinical data IFF IFF $135.21 / -7.9 (-5.52%) 09/16/21 IFF appoints Glenn Richter CFO 08/23/21 IFF sells Microbial Control for $1.3B 08/16/21 Omega Advisors buys Bausch Health, exits Comcast Class A in Q2 05/17/21 Cooperman's Omega added Alibaba in Q1, exited AMC Networks GRTS Gritstone $11.49 / -2.015 (-14.93%) 09/17/21 Gritstone announces dosing of patient in Phase 2 clinical trial of SLATE 09/17/21 Gritstone presents 'positive' clinical data with GRANITE during ESMO 08/17/21 Gritstone, CEPI announce agreement to advance COVID-19 vaccine program 08/11/21 Gritstone to host KOL webinar on neoantigen oncology programs FIVN Five9 $175.22 / +7.19 (+4.28%) 07/19/21 Zoom Video acquires Five9 for $200.28 per share or $14.7B in all-stock deal FANG Diamondback Energy $82.56 / +2.43 (+3.03%) 09/16/21 Diamondback Energy announces $2B repurchase program, 'effective immediately' 08/09/21 Viper Energy to acquire mineral, royalty interests in stock, cash transaction 08/02/21 Diamondback Energy sees FY21 total net production 363 - 370 MBOE/d 05/03/21 Oasis Petroleum to acquire Williston Basin assets from Diamondback for $745M DB Deutsche Bank $12.91 / -0.21 (-1.60%) 07/28/21 Deutsche Bank reaffirms 2022 ratio targets 06/21/21 Deutsche Bank, Fiserv enter payment acceptance joint venture in Germany 04/28/21 Deutsche Bank rises 9.3% 04/28/21 Deutsche Bank CEO confident on reaching 2022 targets CNI Canadian National $118.30 / +2.45 (+2.11%) 09/17/21 CN reaffirms commitment to enhancing competition 09/17/21 CN announces progress on ESG commitments 09/17/21 CN announces value creation plan targeting C$700M of additional operating income 09/15/21 North American rail traffic dropped 2.7% in week ended September 11 BITCOIN Bitcoin / + 08/18/21 Jack Dorsey says he is 'trying' bitcoin mining BGNE BeiGene $403.60 / +18.32 (+4.75%) 09/17/21 BeiGene receives CHMP recommendation for approval of Brukinsa 09/16/21 Leap Therapeutics presents data from first-line cohort of DisTinGuish study 09/15/21 BeiGene director sells 12.9K shares of common stock 09/15/21 BeiGene receives accelerated approval for Brukinsa from FDA AZN AstraZeneca $55.56 / -1.04 (-1.84%) 09/17/21 AstraZeneca says Enhertu showed clinically meaningful, durable response in trial 09/17/21 AstraZeneca's ENHERTU showed 'clinically meaningful' response in Phase II trial 09/17/21 AstraZeneca says Imfinzi combo improves clinical outcomes in COAST Phase 2 study AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 09/17/21 AMC CEO: Ticket buyers to be able to pay in Bitcoin, litecoin, ethereum 09/15/21 AMC Entertainment falls -6.7% 09/08/21 AMC Theatres unveils $25M+ ad campaign featuring Nicole Kidman 09/07/21 AMC Entertainment reports new Labor Day admissions-revenue record ACCD Accolade $45.35 / +0.35 (+0.78%) 04/23/21 Accolade to acquire PlushCare for up to $450M $LTC Litecoin / + 09/13/21 Walmart has no relationship with Litecoin, company says in statement 09/13/21 Litecoin Foundation confirms not in partnership with Walmart 09/13/21 Walmart spokesperson says no partnership with Litecoin $ETH Ethereum / + 08/31/21 WISeKey partners with Polygon to offer NFT solutions 08/25/21 Powerbridge signs purchase agreement for 5,600 BTC, ETh mining machines 08/17/21 Powerbridge enters pact with Cryptodigital to acquire cryptocurrency miners $BTC Bitcoin / + 09/14/21 Ault Global takes delivery of 1,000 s19j Pro Model Antminers 09/08/21 Riot Blockchain reports August Bitcoin production up 451% y/y 09/07/21 MVB Bank, NYDIG partner to offer white label Bitcoin and banking platform TMO FANG X AMC $ETH $BTC BTC BITCOIN $LTC TTWO ACCD LVS WYNN FIVN ZM IVZ STT ZYME UL WFC DB NOG CRK IPHA AZN BGNE PTGX TCRR GRTS MANU CNI IFF PGR MCFT PFE BNTX TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 08/04/21 Credit Suisse Thermo Fisher assumed with an Outperform at Credit Suisse 08/04/21 Argus Thermo Fisher price target raised to $600 from $530 at Argus 07/29/21 Cowen Thermo Fisher price target raised to $560 from $525 at Cowen 07/29/21 BTIG Thermo Fisher price target raised to $610 from $590 at BTIG FANG Diamondback Energy $82.56 / +2.43 (+3.03%) 09/15/21 Truist Diamondback Energy price target raised to $130 from $122 at Truist 07/22/21 Piper Sandler Diamondback Energy price target raised to $112 from $102 at Piper Sandler 07/15/21 Mizuho Diamondback Energy price target raised to $131 from $120 at Mizuho 07/07/21 Wells Fargo Diamondback Energy price target raised to $101 from $90 at Wells Fargo X U.S. Steel $23.36 / -2.03 (-8.00%) 09/15/21 Deutsche Bank U.S. Steel price target raised to $50 from $38 at Deutsche Bank 07/07/21 Credit Suisse Steel demand booming in the U.S., says Credit Suisse 07/01/21 Deutsche Bank U.S. Steel price target raised to $38 from $30 at Deutsche Bank 06/16/21 Fly Intel: Top five analyst downgrades AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 09/01/21 Fly Intel: Top five analyst downgrades 09/01/21 Macquarie AMC Entertainment downgraded to Underperform from Neutral at Macquarie 08/30/21 JPMorgan Movie executives see 10% of screens closing, down from 15%, says JPMorgan 08/24/21 MKM Partners Slow box office to make AMC Entertainment recovery difficult, says MKM Partners $ETH Ethereum / + 05/07/21 Argus Ethan Allen upgraded to Buy from Hold at Argus 05/07/21 Argus Ethan Allen upgraded to Buy from Hold at Argus 11/24/20 UBS RH price target raised to $450 from $380 at UBS $BTC Bitcoin / + 09/08/21 Cowen SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen 08/03/21 Craig-Hallum Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy 04/27/21 Roth Capital Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital 04/15/21 Morgan Stanley WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley BTC Bitcoin / + BITCOIN Bitcoin / + 05/13/21 BTIG BTIG sees Binance news as 'net positive' for Coinbase $LTC Litecoin / + 06/03/21 Mizuho LTC Properties downgraded to Underperform from Neutral at Mizuho 03/30/21 Capital One LTC Properties downgraded to Equalweight from Overweight at Capital One 03/03/21 RBC Capital LTC Properties price target raised to $38 from $33 at RBC Capital 02/09/21 Mizuho LTC Properties price target raised to $38 from $35 at Mizuho TTWO Take-Two $151.79 / -0.1 (-0.07%) 09/17/21 Fly Intel: Top five analyst downgrades 09/17/21 BMO Capital Take-Two downgraded to Market Perform from Outperform at BMO Capital 09/14/21 Ascendiant Take-Two price target lowered to $198 from $216 at Ascendiant 09/13/21 JPMorgan Activision should be bought on China regulation concerns, says JPMorgan ACCD Accolade $45.35 / +0.35 (+0.78%) 09/17/21 Fly Intel: Top five analyst upgrades 09/17/21 Baird Baird upgrades Accolade to Outperform on execution, valuation discount 09/17/21 Baird Accolade upgraded to Outperform from Neutral at Baird 07/13/21 Baird Accolade price target raised to $58 from $54 at Baird LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 09/17/21 Jefferies Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau 09/17/21 Jefferies Las Vegas Sands downgraded to Hold from Buy at Jefferies 09/16/21 JPMorgan JPMorgan downgrades Las Vegas Sands on Macau uncertainty WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) 09/17/21 Argus Wynn Resorts downgraded to Hold from Buy at Argus 09/17/21 Argus Wynn Resorts downgraded to Hold from Buy at Argus 09/16/21 JPMorgan Wynn Resorts downgraded on Macau uncertainty at JPMorgan FIVN Five9 $175.22 / +7.19 (+4.28%) 09/17/21 Piper Sandler Piper upgrades Five9 on potential for increased Zoom takeover bid 09/17/21 Piper Sandler Five9 upgraded to Overweight from Neutral at Piper Sandler 09/09/21 JMP Securities Nice price target raised to $343 from $302 at JMP Securities 09/07/21 Needham Five9 upgraded to Buy from Hold at Needham ZM Zoom Video $287.58 / +9.63 (+3.46%) 09/03/21 UBS DocuSign price target raised to $350 from $340 at UBS IVZ Invesco $26.25 / +1.37 (+5.51%) 09/17/21 Deutsche Bank State Street, Invesco deal would be 'strategically compelling,' says Deutsche 09/17/21 Citi Citi doubts State Street will buy Invesco outright, expects share pullback 07/12/21 Deutsche Bank Invesco price target raised to $35 from $33 at Deutsche Bank 07/12/21 Citi Invesco upgraded to Buy from Neutral at Citi STT State Street $84.81 / -2.195 (-2.52%) 09/09/21 JPMorgan JPMorgan expects 'sizable equity issue' from State Street after deal 09/08/21 Jefferies State Street pullback on BBH deal a buying opportunity, says Jefferies ZYME Zymeworks $35.62 / -0.435 (-1.21%) 09/13/21 Raymond James Zymeworks data continue to outperform Herceptin, says Raymond James 08/05/21 H.C. Wainwright Zymeworks price target lowered to $44 from $55 at H.C. Wainwright 03/30/21 Credit Suisse Zymeworks initiated with an Outperform at Credit Suisse 03/30/21 Credit Suisse Zymeworks initiated with an Outperform at Credit Suisse UL Unilever $53.95 / -0.585 (-1.07%) 09/16/21 Deutsche Bank Unilever downgraded to Hold from Buy at Deutsche Bank 09/02/21 Fly Intel: Top five analyst downgrades 09/02/21 JPMorgan Unilever downgraded to Underweight from Neutral at JPMorgan 08/06/21 Morgan Stanley Unilever upgraded to Equal Weight from Underweight at Morgan Stanley WFC Wells Fargo $46.46 / +0.17 (+0.37%) 09/16/21 JPMorgan JPMorgan does not expect Wells Fargo to be broken up 09/10/21 JPMorgan Wells Fargo OCC fine 'moderate and manageable,' says JPMorgan 09/10/21 Morgan Stanley Wells Fargo fine 'much lower' than Street baked in, says Morgan Stanley 09/01/21 Morgan Stanley Morgan Stanley says Wells already warned investors more penalties could come DB Deutsche Bank $12.91 / -0.21 (-1.60%) 09/17/21 JPMorgan Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan 08/13/21 Fly Intel: Top five analyst upgrades 08/13/21 Keefe Bruyette Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette 07/29/21 Credit Suisse Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse NOG Northern Oil and Gas $17.32 / -1.12 (-6.07%) 09/01/21 Raymond James Northern Oil and Gas price target raised to $32 at Raymond James 07/22/21 Piper Sandler Northern Oil and Gas upgraded to Overweight from Neutral at Piper Sandler 07/01/21 Truist Northern Oil and Gas price target raised to $33 from $25 at Truist 06/23/21 Piper Sandler Northern Oil and Gas initiated with a Neutral at Piper Sandler CRK Comstock Resources $8.66 / -0.2 (-2.26%) 07/15/21 Mizuho Comstock Resources price target raised to $10 from $8 at Mizuho 07/13/21 Mizuho Comstock Resources price target raised to $10 from $8 at Mizuho 04/20/21 Mizuho Comstock Resources price target lowered to $8 from $9 at Mizuho 03/23/21 Citi Comstock Resources price target lowered to $7 from $8 at Citi IPHA Innate Pharma $8.07 / +2.31 (+40.10%) 09/17/21 Evercore ISI Innate Pharma price target raised to $10 from $6 at Evercore ISI 09/02/21 SVB Leerink SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform 09/02/21 SVB Leerink Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink 12/15/20 Fly Intel: Top five analyst downgrades AZN AstraZeneca $55.56 / -1.04 (-1.84%) 09/17/21 Morgan Stanley AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley 09/09/21 RBC Capital Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital 08/12/21 JPMorgan AstraZeneca resumed with an Overweight at JPMorgan BGNE BeiGene $403.60 / +18.32 (+4.75%) 06/14/21 SVB Leerink BeiGene price target raised to $417 from $388 at SVB Leerink 03/16/21 HSBC BeiGene price target raised to $385 from $296 at HSBC 03/08/21 China Renaissance BeiGene initiated with a Buy at China Renaissance 03/04/21 Goldman Sachs Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs PTGX Protagonist Therapeutics $17.60 / -28.53 (-61.85%) 09/17/21 Piper Sandler Protagonist selloff 'overdone' following clinical hold, says Piper Sandler 09/17/21 Piper Sandler Protagonist clinical hold brings more questions than answers, says Piper Sandler 08/06/21 H.C. Wainwright Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright 08/05/21 SVB Leerink Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink TCRR TCR2 Therapeutics $10.00 / -5.715 (-36.38%) 09/17/21 Wedbush TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush 08/06/21 BMO Capital TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital 06/24/21 Goldman Sachs TCR2 Therapeutics initiated with a Buy at Goldman Sachs 06/11/21 BMO Capital TCR2 Therapeutics coverage transferred at BMO Capital GRTS Gritstone $11.49 / -2.015 (-14.93%) 01/21/21 BTIG Gritstone Oncology price target raised to $35 from $17 at BTIG 01/20/21 H.C. Wainwright Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright 01/20/21 Baird Gritstone Oncology downgraded to Underperform from Outperform at Baird MANU Manchester United $18.00 / +0.375 (+2.13%) 04/06/21 Deutsche Bank Manchester United price target raised to $17 from $16 at Deutsche Bank CNI Canadian National $118.30 / +2.45 (+2.11%) 09/17/21 RBC Capital Canadian National reinstated at Outperform from Sector Perform at RBC Capital 09/16/21 National Bank Canadian National price target raised to C$144 from C$139 at National Bank 09/15/21 Wolfe Research Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research 09/14/21 TD Securities Canadian National downgraded to Hold from Buy at TD Securities IFF IFF $135.21 / -7.9 (-5.52%) 07/20/21 Redburn IFF initiated with a Buy at Redburn 06/28/21 Wells Fargo IFF price target raised to $168 from $160 at Wells Fargo 05/13/21 Jefferies IFF price target raised to $160 from $155 at Jefferies 05/12/21 Wells Fargo IFF price target raised to $160 from $155 at Wells Fargo PGR Progressive $92.64 / -0.35 (-0.38%) 08/17/21 Evercore ISI Progressive added to 'Tactical Underperform List' at Evercore ISI 08/16/21 Wolfe Research Progressive initiated with an Underperform at Wolfe Research 07/16/21 Barclays Progressive price target lowered to $84 from $86 at Barclays 07/09/21 BofA Progressive added to US 1 List; Arch Capital removed at BofA MCFT MasterCraft Boat $25.60 / +0.03 (+0.12%) 09/02/21 Baird MasterCraft Boat trading at 'absurd valuation,' says Baird 06/17/21 Truist MasterCraft Boat price target lowered to $28 from $32 at Truist 05/13/21 Truist MasterCraft Boat price target raised to $32 from $26 at Truist 05/13/21 B. Riley MasterCraft Boat price target raised to $45 from $40 at B. Riley PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Evercore ISI Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters 09/16/21 Canaccord Exact Sciences salesforce expansion a net positive, says Canaccord 09/16/21 BofA Moderna boosters already reflected in 'bullish' consensus, says BofA 09/15/21 Raymond James Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/27/21 UBS BioNTech price target raised to $300 from $111 at UBS 08/20/21 Canaccord BioNTech price target raised to $450 from $240 at Canaccord 08/12/21 Wells Fargo Wells says Moderna vaccine looks more effective than Pfizer's against Delta ZYME ZM X WYNN WFC TTWO TMO TCRR STT PTGX PGR PFE NOG MCFT MANU LVS IVZ IFF GRTS FIVN FANG DB CRK CNI BNTX BITCOIN BGNE AZN AMC ACCD $LTC $ETH $BTC ZYME Zymeworks $35.62 / -0.435 (-1.21%) 08/04/21 Zymeworks reports Q2 EPS ($1.31), consensus ($1.05) 05/05/21 Zymeworks reports Q1 EPS (87c), consensus ($1.03) ZM Zoom Video $287.58 / +9.63 (+3.46%) 08/30/21 Zoom Video raises FY22 EPS view to $4.75-$4.79 from $4.56-$4.61 08/30/21 Zoom Video sees Q3 EPS $1.07-$1.08, consensus $1.09 08/30/21 Zoom Video reports Q2 EPS $1.36, consensus $1.16 08/30/21 Notable companies reporting after market close X U.S. Steel $23.36 / -2.03 (-8.00%) 09/16/21 U.S. Steel sees Q3 adjusted EBITDA roughly $2B 07/29/21 U.S. Steel reports Q2 adjusted EPS $3.37, consensus $3.05 06/17/21 U.S. Steel sees Q2 EPS about $3.08, consensus $2.67 04/29/21 U.S. Steel reports Q1 adjusted EPS $1.08, consensus 91c WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) 08/04/21 Wynn Resorts reports Q2 EPS ($1.15), consensus ($1.52) 08/04/21 Notable companies reporting after market close 05/10/21 Wynn Resorts reports Q1 EPS ($2.41), consensus ($1.98) 05/10/21 Notable companies reporting after market close WFC Wells Fargo $46.46 / +0.17 (+0.37%) 07/14/21 Wells Fargo reports Q2 EPS $1.38, consensus 97c 07/14/21 Wells Fargo reports Q2 EPS $1.38, consensus 97c 07/13/21 Notable companies reporting before tomorrow's open TTWO Take-Two $151.79 / -0.1 (-0.07%) 09/09/21 Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.58 08/02/21 Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.72 08/02/21 Take-Two sees Q2 EPS 35c-45c, consensus $1.36 08/02/21 Take-Two reports Q1 GAAP EPS $1.30, consensus 89c TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 09/17/21 Thermo Fisher affirms FY21 adjusted EPS view $22.07, consensus $22.16 09/17/21 Thermo Fisher sees FY22 adjusted EPS of $21.16, consensus $19.68 07/28/21 Thermo Fisher raises FY21 adjusted EPS view to $22.07 from $21.97 07/28/21 Thermo Fisher reports Q2 adjusted EPS $5.60, consensus $5.49 TCRR TCR2 Therapeutics $10.00 / -5.715 (-36.38%) 08/05/21 TCR2 Therapeutics reports Q2 EPS (64c), consensus (59c) STT State Street $84.81 / -2.195 (-2.52%) 07/16/21 State Street reports Q2 ex-items EPS $1.97, consensus $1.79 07/15/21 Notable companies reporting before tomorrow's open 04/16/21 State Street reports Q1 ex-items EPS $1.47, consensus $1.35 PTGX Protagonist Therapeutics $17.60 / -28.53 (-61.85%) 08/04/21 Protagonist Therapeutics reports Q2 EPS (69c), consensus (51c) 05/04/21 Protagonist Therapeutics reports Q1 EPS (54c), consensus (57c) PGR Progressive $92.64 / -0.35 (-0.38%) 09/17/21 Progressive reports August EPS (2c) vs. 83c last year 09/16/21 Notable companies reporting before tomorrow's open 08/18/21 Progressive reports July EPS 43c vs. $1.38 last year 07/15/21 Progressive reports June EPS 22c vs. 80c last year PFE Pfizer $43.89 / -0.57 (-1.28%) 07/28/21 Pfizer raises FY21 adjusted EPS view to $3.95-$4.05 from $3.55-$3.65 07/28/21 Pfizer reports Q2 adjusted EPS $1.07, consensus 96c 07/27/21 Notable companies reporting before tomorrow's open NOG Northern Oil and Gas $17.32 / -1.12 (-6.07%) 08/05/21 Northern Oil and Gas reports Q2 EPS ($1.55), consensus 67c 05/07/21 Northern Oil and Gas reports Q1 adjusted EPS 74c, consensus 54c MCFT MasterCraft Boat $25.60 / +0.03 (+0.12%) 09/17/21 MasterCraft Boat reaffirms guidance for FY22 09/17/21 MasterCraft sees Q1 adj. EPS decreasing in low-double digit percentage range 09/02/21 MasterCraft Boat sees Q1 adjusted EPS growth low-20% range y-o-y 09/02/21 MasterCraft Boat sees FY22 adjusted EPS growth high-teens percentage y-o-y MANU Manchester United $18.00 / +0.375 (+2.13%) 09/17/21 Manchester United reports Q4 adjusted EPS (GBp 20.67) vs. (GBp 21.59) last year 06/17/21 Manchester United reports Q3 adjusted EPS GBp (13.30) vs (4.42) last year LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 07/21/21 Las Vegas Sands reports Q2 hold-normalized adjusted EPS (29c), consensus (13c) 07/21/21 Las Vegas Sands reports Q2 EPS (25c), consensus (13c) 07/21/21 Notable companies reporting after market close 04/21/21 Las Vegas Sands reports Q1 EPS (36c), consensus (26c) IVZ Invesco $26.25 / +1.37 (+5.51%) 07/27/21 Invesco reports Q2 adjusted EPS 78c, consensus 69c 04/27/21 Invesco reports Q1 adjusted EPS 68c, consensus 62c 04/26/21 Notable companies reporting before tomorrow's open IFF IFF $135.21 / -7.9 (-5.52%) 09/16/21 IFF sees FY21 sales growth greater than 8%, adjusted EBITDA margin around 21.5% 08/05/21 IFF raises FY21 revenue view to roughly $11.4B from $11.25B 08/05/21 IFF reports Q2 adjusted EPS $1.50, consensus $1.48 05/10/21 IFF sees 2021 sales $11.25B, consensus $11.1B GRTS Gritstone $11.49 / -2.015 (-14.93%) 08/05/21 Gritstone reports Q2 EPS (33c), consensus (58c) 05/06/21 Gritstone Oncology reports Q1 EPS 10c, consensus (39c) FIVN Five9 $175.22 / +7.19 (+4.28%) 07/27/21 Five9 reports Q2 EPS 23c, consensus 14c 04/29/21 Five9 raises FY21 EPS view to 89c-93c, consensus 76c 04/29/21 Five9 sees Q2 EPS 13c-14c, consensus 12c 04/29/21 Five9 reports Q1 EPS 23c, consensus 13c FANG Diamondback Energy $82.56 / +2.43 (+3.03%) 08/02/21 Diamondback Energy reports Q2 EPS $2.40, consensus 12c 05/03/21 Diamondback Energy reports Q1 adjusted EPS $2.30, consensus $1.80 DB Deutsche Bank $12.91 / -0.21 (-1.60%) 07/28/21 Deutsche Bank reports Q2 net profit EUR828M vs. EUR61M last year 04/28/21 Deutsche Bank reports Q1 net profit EUR1B vs. EUR66M last year CRK Comstock Resources $8.66 / -0.2 (-2.26%) 08/03/21 Comstock Resources reports Q2 adjusted EPS 22c, consensus 16c 05/04/21 Comstock Resources reports Q1 EPS 25c, consensus 13c CNI Canadian National $118.30 / +2.45 (+2.11%) 09/17/21 CN reaffirms 2021 financial outlook targets 07/20/21 Canadian National backs double-digit adjusted diluted EPS growth vs. last year 07/20/21 Canadian National reports Q2 adjusted EPS C$1.49 versus C$1.28 in last years Q2 04/26/21 Canadian National raises FY21 EPS view to up double-digits BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/09/21 BioNTech sees 2021 capex EUR 175M - EUR 225M 08/09/21 BioNTech reports Q2 EPS EUR 10.77 vs. (EUR 0.38) last year 05/10/21 BioNTech reports Q1 EPS EUR 4.39 vs. (EUR 0.24) last year BITCOIN Bitcoin / + 04/22/21 Fly Intel: What to watch in credit card space earnings reports BGNE BeiGene $403.60 / +18.32 (+4.75%) 08/05/21 BeiGene reports Q2 EPS ($5.23), consensus ($4.14) 05/06/21 BeiGene reports Q1 EPS 69c vs. ($4.70) a year ago. AZN AstraZeneca $55.56 / -1.04 (-1.84%) 07/29/21 AstraZeneca sees FY21 core EPS $5.05-$5.40, consensus $5.14 07/29/21 AstraZeneca reports Q2 core EPS 90c, consensus 92c 04/30/21 AstraZeneca sees FY21 EPS $4.75-$5.00, consensus $2.11 04/30/21 AstraZeneca reports Q1 core EPS $1.63, one estimate 75c AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 08/09/21 AMC Entertainment reports Q2 adjusted EPS (71c), consensus (93c) 08/09/21 Notable companies reporting after market close 07/13/21 Fly Intel: What to watch in next round of big bank earnings reports 05/06/21 AMC Entertainment reports Q1 adjusted EPS ($1.42), consensus ($1.30) ACCD Accolade $45.35 / +0.35 (+0.78%) 07/08/21 Accolade raises FY22 revenue view to $300M-$305M, consensus $277.86M 07/08/21 Accolade reports Q1 EPS (84c), consensus (37c) 05/05/21 Accolade reports Q4 revenue $59.23M, consensus $56.57M. 03/23/21 Accolade sees Q4 adjusted EBITDA 60c-$2.10 $LTC Litecoin / + 07/29/21 LTC Properties reports Q2 FFO 57c, consensus 68c 04/29/21 LTC Properties reports Q1 FFO 62c, consensus 69c $ETH Ethereum / + 08/09/21 Ethan Allen reports Q4 EPS 74c, consensus 65c 04/29/21 Ethan Allen reports Q3 adjusted EPS 58c, two estimates 57c 04/14/21 Ethan Allen reports preliminary Q3 adjusted EPS 56c-58c, two estimates 47c $BTC Bitcoin / + 08/23/21 Riot Blockchain reports Q2 EPS 22c, consensus 5c 08/17/21 CleanSpark reports Q3 non-GAAP EPS 7c, consensus 7c 07/22/21 Fly Intel: What to watch in credit card space earnings reports 05/05/21 Fly Intel: What to watch in PayPal earnings report 10 Sep 17 Jun 16 Jun 04 Jun 12 Mar 09 Feb 05 Feb 03 Feb 20 Jan 13 Jan 11 Dec 02 Dec 22 Oct ZYME ZM X WYNN WFC UL TTWO TMO STT PGR PFE NOG MANU LVS IVZ FIVN DB CNI BITCOIN BGNE AZN AMC $LTC $ETH $BTC ZYME Zymeworks $35.62 / -0.435 (-1.21%) 09/17/21 Zymeworks data 'could intensify potential sale talks,' Dealreporter says ZM Zoom Video $287.58 / +9.63 (+3.46%) 08/01/21 Zoom reaches $85M settlement over user privacy, Reuters reports 07/21/21 Zoom Video in talks to invest in Cvent-SPAC deal, Bloomberg says 07/21/21 Zoom Video in talks to invest in Cvent-SPAC deal, Bloomberg says X U.S. Steel $23.36 / -2.03 (-8.00%) 09/10/21 U.S. submits offer to settle steel tariff fight with EU, Bloomberg says 09/10/21 U.S. submits offer to settle steel tariff fight with EU, Bloomberg says 05/01/21 Steel stocks due for a fall, Barron' says 03/24/21 Steel complex lobbies Biden administration on Trump tariffs, Bloomberg says WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) 08/12/21 NFL adds PointsBet/BetMGM/WynnBet in sports betting deals, Sportico says WFC Wells Fargo $46.46 / +0.17 (+0.37%) 09/17/21 Fed opposed Deutsche Bank idea of buying Wells' custody unit, Bloomberg says 09/17/21 Fed opposed Deutsche Bank idea of buying Wells' custody unit, Bloomberg says 09/14/21 Wells Fargo again delays return-to-office plans to November 1, Bloomberg reports 09/14/21 Senator Warren asks Federal Reserve to break up Wells Fargo, NY Times reports UL Unilever $53.95 / -0.585 (-1.07%) 09/17/21 NJ to pull invesments worth $182M from Unilever, NY Times reports 07/20/21 Israel warns Unilever of consequences from Ben & Jerry's boycott, Reuters says TTWO Take-Two $151.79 / -0.1 (-0.07%) 08/12/21 Take-Two working on remastered versions of older 'GTA' games, Kotaku says 08/10/21 Lawmakers call on game companies to avoid predatory designs, Verge reports 07/19/21 Nintendo's new 'Zelda' tops U.K. physical game sales chart, Nintendo Life says 05/21/21 Netflix looking to hire to expand in video games, The Information says TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 04/15/21 Syneos could be CRO 'target still standing when music stops,' Dealreporter says 04/14/21 Thermo Fisher near deal to buy PPD for over $15B, WSJ reports 04/14/21 PPD jumps 13% after report of Thermo Fisher takeover talks 04/14/21 Thermo Fisher near deal to buy drug-testing company PPD for over $15B, WSJ says STT State Street $84.81 / -2.195 (-2.52%) 08/16/21 State Street vacating Midtown Manhattan offices, WSJ reports 04/09/21 Credit Suisse asset management arm receiving interest, Reuters reports 03/26/21 SocGen in discussions with Amundi, State Street to sell Lyxor unit, Reuters says PGR Progressive $92.64 / -0.35 (-0.38%) 05/01/21 Progressive 'a growth stock' in slow-growth industry, Barron's says PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel plans earlier than scheduled vote on Pfizer booster, Bloomberg says 09/17/21 U.S. buying hundreds of millions more Pfizer vaccine to donate, WaPo reports 09/17/21 FDA panel to review data on Covid booster shots, WSJ reports 09/16/21 Moderna's Hoge tells CNBC Delta variant has exposed vaccine weaknesses NOG Northern Oil and Gas $17.32 / -1.12 (-6.07%) 09/17/21 Northern Oil front-runner to buy stake in Comstock's Bakken assets, Reuters says 09/17/21 Northern Oil front-runner to buy stake in Comstock's Bakken assets, Reuters says MANU Manchester United $18.00 / +0.375 (+2.13%) 04/20/21 Woodward steps down as Manchester United executive vice chairman, Sky News says LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 09/14/21 Macau to launch public consultation for revision to gaming law, GGR Asia reports 08/19/21 North Carolina Senate approves sports betting bill, iGB reports 08/12/21 Canadians can bet single-sport wagers starting August 27, Yahoo reports 08/04/21 Macau closing cinemas, theaters amid Covid resurgence, Reuters reports IVZ Invesco $26.25 / +1.37 (+5.51%) 09/16/21 Invesco in talks over tie-up with State Street's asset management unit, WSJ says FIVN Five9 $175.22 / +7.19 (+4.28%) 09/17/21 ISS recommends vote against Zoom Video deal to buy Five9, CNBC's Faber says DB Deutsche Bank $12.91 / -0.21 (-1.60%) 09/15/21 Deutsche Bank CEO Sewing praised for fixing the bank, Bloomberg reports 09/14/21 Deutsche Bank contacts external candidates in chairman search, Bloomberg says CNI Canadian National $118.30 / +2.45 (+2.11%) 09/12/21 Kansas City Southern plans to accept Canadian Pacific's $27B bid, Reuters says 09/03/21 Kansas City Southern board to open talks with Canadian Pacific, CNBC reports 09/01/21 Activist urges Canadian National CEO, chair to resign, FT reports 08/09/21 Canadian Pacific plans higher bid for Kansas City Southern, WSJ reports BITCOIN Bitcoin / + 07/26/21 Amazon denies will accept bitcoin, launch crypto coin in 2022, Bloomberg says BGNE BeiGene $403.60 / +18.32 (+4.75%) 08/25/21 SEC chief says 'clock is ticking' on U.S listed China stocks, Bloomberg says AZN AstraZeneca $55.56 / -1.04 (-1.84%) 09/09/21 Biden administration plans to lower prescription drug prices, WSJ reports 08/30/21 AstraZeneca mandates vaccines for U.S. workers, NYT reports 08/01/21 Pfizer, Moderna increase EU COVID-19 vaccine pricing, FT reports 07/26/21 AstraZeneca says Thai vaccine production has been 'complicated,' FT reports AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 09/08/21 AMC CEO tells Fox Business it made contact with GameStop over partnership 08/13/21 House panel shelves plans to ban payment for order flow, FBN's Gasparino says 08/09/21 AMC to show Warner's 2022 films for exclusive 45-day window, Variety says 08/09/21 Movie theaters release quarterly results, slow revenue improvement, WSJ reports $LTC Litecoin / + 07/01/21 Indian crypto try to find payment solutions after banks cut ties, Reuters report 06/10/21 Coinbase works with 401k provider ForUsAll to offer crypto, WSJ reports $ETH Ethereum / + 09/01/21 SEC's Gensler 'warns' crypto platforms need to abide U.S. public policy, FT says 08/10/21 Ethan Allen CEO tells CNBC production backlogs to be resolved in 4-6 months 08/09/21 Senators reach bipartisan pact on crypto reporting amendment, The Hill says 07/20/21 Crypto exchange FTX valued $18B after latest funding round, WSJ says $BTC Bitcoin / + 08/24/21 Citi awaiting approval to trade bitcoin futures, CoinDesk reports ZM X WFC UL TTWO TMO PGR MANU LVS FIVN FANG DB CRK CNI AZN AMC ACCD $LTC $ETH ZM Zoom Video $287.58 / +9.63 (+3.46%) 09/15/21 #SocialStocks: Facebook faces new probe regarding negative impact on teenagers 09/01/21 #SocialStocks: Zoom Q2 earnings and guidance fail to impress analysts X U.S. Steel $23.36 / -2.03 (-8.00%) 06/18/21 Wall Street in Fives - Must Read Lists for Friday 06/18/21 Wall Street in Fives - Must Read Lists at Midday WFC Wells Fargo $46.46 / +0.17 (+0.37%) 09/14/21 Wall Street in Fives - Must Read Lists for Tuesday 09/14/21 Wall Street in Fives - Must Read Lists at Midday 08/31/21 Wall Street in Fives - Must Read Lists for Tuesday 07/14/21 Wall Street in Fives - Must Read Lists for Wednesday UL Unilever $53.95 / -0.585 (-1.07%) 09/02/21 Wall Street in Fives - Must Read Lists for Thursday 09/02/21 Wall Street in Fives - Must Read Lists at Midday 09/02/21 AB InBev, Unilever under pressure as JPMorgan says sell ahead of earnings cuts TTWO Take-Two $151.79 / -0.1 (-0.07%) 09/17/21 Take-Two downgrade among today's top calls on Wall Street 09/17/21 Fly Intel: Pre-market Movers 09/14/21 Game On: Judge issues permanent injunction against Apple in Epic case TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 09/17/21 Wall Street in Fives - Must Read Lists at Midday 07/28/21 Fly Intel: Pre-market Movers 04/29/21 Fly Intel: Pre-market Movers 04/15/21 Fly Intel: Wall Street's top stories for Thursday PGR Progressive $92.64 / -0.35 (-0.38%) 07/15/21 Wall Street in Fives - Must Read Lists for Thursday 07/15/21 Wall Street in Fives - Must Read Lists at Midday MANU Manchester United $18.00 / +0.375 (+2.13%) 08/27/21 Wall Street in Fives - Must Read Lists for Friday 04/19/21 Fly Intel: Pre-market Movers LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 09/17/21 Bet On It: Expanding sports betting market feasts on Week 1 of NFL season 09/16/21 Wall Street in Fives - Must Read Lists for Thursday 09/16/21 Wall Street in Fives - Must Read Lists at Midday FIVN Five9 $175.22 / +7.19 (+4.28%) 09/08/21 #SocialStocks: WhatsApp in hot water over lack of privacy 08/26/21 Morgan Stanley says buy Zoom Video ahead of results, sees concerns overblown 07/29/21 Zoom Video, Spotify upgrades among today's top calls on Wall Street FANG Diamondback Energy $82.56 / +2.43 (+3.03%) 09/16/21 Fly Intel: After-Hours Movers DB Deutsche Bank $12.91 / -0.21 (-1.60%) 08/03/21 Wall Street in Fives - Must Read Lists for Tuesday 08/03/21 Wall Street in Fives - Must Read Lists at Midday 05/27/21 Wall Street in Fives - Must Read Lists for Thursday CRK Comstock Resources $8.66 / -0.2 (-2.26%) 06/04/21 Wall Street in Fives - Must Read Lists for Friday 06/04/21 Wall Street in Fives - Must Read Lists at Midday CNI Canadian National $118.30 / +2.45 (+2.11%) 09/15/21 Wall Street in Fives - Must Read Lists for Wednesday 09/15/21 Wall Street in Fives - Must Read Lists at Midday AZN AstraZeneca $55.56 / -1.04 (-1.84%) 08/30/21 Wall Street in Fives - Must Read Lists for Monday 08/30/21 Wall Street in Fives - Must Read Lists at Midday 06/15/21 Wall Street in Fives - Must Read Lists for Tuesday AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 09/17/21 Crypto Currents: AMC ticket buyers to be able to pay in crypto 09/07/21 Wall Street in Fives - Must Read Lists for Tuesday 09/07/21 Wall Street in Fives - Must Read Lists at Midday ACCD Accolade $45.35 / +0.35 (+0.78%) 07/09/21 Wall Street in Fives - Must Read Lists for Friday 07/09/21 Wall Street in Fives - Must Read Lists at Midday $LTC Litecoin / + 09/13/21 Wall Street in Fives - Must Read Lists at Midday $ETH Ethereum / + 09/10/21 Crypto Currents: Coinbase receives Wells Notice from SEC on Lend program 09/03/21 Crypto Currents: SEC Chair says crypto platforms need regulation 09/23/21 Biotechnology 09/19/21 GroceryShop 09/27/21 Global Healthcare Virtual Conference 10/06/21 29th Annual Leveraged Finance Virtual Conference 2021 12/01/21 NASH 2021: Stephens Annual Investment Conference 09/17/21 Manchester United - MANU 09/17/21 TCR2 Therapeutics - TCRR 10/07/21 Accolade - ACCD 10/14/21 Wells Fargo - WFC 10/19/21 Canadian National - CNI 11/09/21 BioNTech - BNTX 09/17/21 Vaccines and Related Biological Products Advisory Committee Meeting 10/18/21 PDUFA Date for Brukinsa Zanubrutinib (BGB-3111) 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 05/06/22 PDUFA Date for MYFEMBREE 09/17/21 Thermo Fisher Scientific Inc. 09/24/21 Pfizer 09/30/21 Five9, Inc. 10/19/21 MasterCraft Boat Holdings, Inc. 10/20/21 TCR2 Therapeutics 10/22/21 TCR2 Therapeutics Inc. ZM X WYNN WFC TTWO TMO STT PGR PFE MANU LVS IVZ FANG DB CNI AZN AMC ACCD $ETH ZM Zoom Video $287.58 / +9.63 (+3.46%) 09/01/21 Notable open interest changes for September 1st 08/30/21 Zoom Video Communications options imply 12.8% move in share price post-earnings 08/26/21 Unusually active option classes on open August 26th 08/04/21 Zoom Video Communications call volume above normal and directionally bullish X U.S. Steel $23.36 / -2.03 (-8.00%) 09/15/21 US Steel call volume above normal and directionally bullish 08/10/21 US Steel call volume above normal and directionally bullish 07/12/21 US Steel call volume above normal and directionally bullish 07/09/21 US Steel call volume above normal and directionally bullish WYNN Wynn Resorts $83.30 / -1.095 (-1.30%) 09/15/21 Unusually active option classes on open September 15th 09/14/21 Unusually active option classes on open September 14th 09/07/21 Wynn Resorts call volume above normal and directionally bullish 08/24/21 Early notable gainers among liquid option names on August 24th WFC Wells Fargo $46.46 / +0.17 (+0.37%) 09/14/21 $9M Wells Fargo straddle buyer looks opening 09/13/21 Wells Fargo call volume above normal and directionally bullish 09/02/21 Notable open interest changes for September 2nd 09/01/21 Unusually active option classes on open September 1st TTWO Take-Two $151.79 / -0.1 (-0.07%) 08/31/21 Early notable gainers among liquid option names on August 31st 07/30/21 Unusually active option classes on open July 30th 07/08/21 TakeTwo Interactive Software put volume heavy and directionally bearish 05/19/21 Early notable gainers among liquid option names on May 19th TMO Thermo Fisher $596.98 / +36.11 (+6.44%) 09/17/21 Early notable gainers among liquid option names on September 17th STT State Street $84.81 / -2.195 (-2.52%) 07/16/21 Early notable gainers among liquid option names on July 16th PGR Progressive $92.64 / -0.35 (-0.38%) 04/15/21 Early notable gainers among liquid option names on April 15th PFE Pfizer $43.89 / -0.57 (-1.28%) 09/14/21 Pfizer put buyer realizes 95% same-day gains 08/24/21 Notable open interest changes for August 24th 08/23/21 Unusually active option classes on open August 23rd 08/19/21 Notable open interest changes for August 19th MANU Manchester United $18.00 / +0.375 (+2.13%) 05/19/21 Unusually active option classes on open May 19th LVS Las Vegas Sands $38.17 / +0.66 (+1.76%) 09/17/21 Las Vegas Sands call buyer realizes 10% same-day gains 09/16/21 Las Vegas Sands call volume above normal and directionally bullish 09/15/21 Notable open interest changes for September 15th 09/15/21 Las Vegas Sands call buyer realizes 46% same-day gains IVZ Invesco $26.25 / +1.37 (+5.51%) 06/02/21 Early notable gainers among liquid option names on June 2nd FANG Diamondback Energy $82.56 / +2.43 (+3.03%) 09/15/21 Early notable gainers among liquid option names on September 15th 08/23/21 Early notable gainers among liquid option names on August 23rd 06/23/21 Early notable gainers among liquid option names on June 23rd DB Deutsche Bank $12.91 / -0.21 (-1.60%) 08/19/21 Deutsche Bank put volume heavy and directionally bearish 06/21/21 Deutsche Bank call volume above normal and directionally bullish 05/24/21 Deutsche Bank call volume above normal and directionally bullish 05/07/21 Deutsche Bank put volume heavy and directionally bearish CNI Canadian National $118.30 / +2.45 (+2.11%) 08/20/21 Canadian National put volume heavy and directionally bearish 07/20/21 Canadian National options imply 6.1% move in share price post-earnings 06/11/21 Largest borrow rate increases among liquid names AZN AstraZeneca $55.56 / -1.04 (-1.84%) 08/24/21 AstraZeneca put volume heavy and directionally bearish 08/13/21 AstraZeneca call volume above normal and directionally bullish 08/12/21 AstraZeneca call volume above normal and directionally bullish 08/09/21 Opening call seller in AstraZeneca AMC AMC Entertainment $44.23 / -1.82 (-3.95%) 09/14/21 Notable open interest changes for September 14th 09/10/21 Notable open interest changes for September 10th 09/08/21 Notable open interest changes for September 8th 09/07/21 Notable open interest changes for September 7th ACCD Accolade $45.35 / +0.35 (+0.78%) 07/08/21 Accolade options imply 9.5% move in share price post-earnings $ETH Ethereum / + 08/16/21 Two new option listings and two option delistings on August 16th

Options	Preliminary option volume of 46.5M today » 16:30 09/17/21 09/17 16:30 09/17/21 16:30 Preliminary option volume… Preliminary option volume of 46.5M today is 26% above recent average. Calls led puts 27.23M to 19.26M.
General news	Treasury Market Summary » 16:30 09/17/21 09/17 16:30 09/17/21 16:30 $ECON Economic Data / + Treasury Market Summary:… Treasury Market Summary: Treasuries extended this week's losses with longer dated yields cheapening another couple of basis points and continuing to unwind the rally following Tuesday's tepid CPI data. Stronger than expected data and Fed angst has weighed on bonds as bulls have been sidelined. The 10-year has risen for 3 straight sessions to hit an intraday high of 1.384% before paring losses back to the 1.36% area. Wall Street ended a choppy week in the red with the S&P 500 and NASDAQ underperforming, falling -0.9% as rising rates weighed heavily on tech. The Dow was -0.48% lower. The uncertainties over the Fed, worries about tax hikes, covid and supply chain headwinds, and fears over China amid the regulatory crackdown/Evergrande problems have made for a very jittery investment environment. And the day's slippage saw the major indexes post declines for the week. Consumer sentiment was the only data, and it edged up a smaller than expected 0.7 ticks to 71.0. ShowHide Related Items >><< Street Research Periodicals $ECON Economic Data / + $ECON Economic Data / + 07/01/21 U.S. secures international backing for global minimum tax rate, WSJ reports 06/03/21 Biden offers tax floor for businesses as infrastructure compromise, WaPo say
Hot Stocks	FDA panel votes 18-0 for EUA for Pfizer booster for people 65+ » 16:27 09/17/21 09/17 16:27 09/17/21 16:27 PFE Pfizer $43.89 / -0.57 (-1.28%) , MRNA Moderna $429.30 / -11.54 (-2.62%) , BNTX BioNTech $358.75 / -13.75 (-3.69%) The panel said that known… The panel said that known and potential benefits outweigh known and potential risks of the Pfizer vaccine booster at least six months out for us in adutls 65 and older and those at high risk of severe COVID-19. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel votes in favor of recommending Pfizer booster for people aged 65+ 09/17/21 Pfizer, Moderna lower after panel votes on booster recommendation 09/17/21 FDA panel votes against recommending booster dose of Pfizer COVID vaccine 09/16/21 Pfizer-BioNTech's Comirnaty gets full Health Canada approval for 12 and older MRNA Moderna $429.30 / -11.54 (-2.62%) 09/16/21 Moderna says Canada approves Covid vaccine for ages 12 and older PFE MRNA BNTX PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Evercore ISI Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters 09/16/21 Canaccord Exact Sciences salesforce expansion a net positive, says Canaccord 09/16/21 BofA Moderna boosters already reflected in 'bullish' consensus, says BofA 09/15/21 Raymond James Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James MRNA Moderna $429.30 / -11.54 (-2.62%) 08/12/21 Wells Fargo Wells says Moderna vaccine looks more effective than Pfizer's against Delta 08/06/21 Fly Intel: Top five analyst downgrades BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/27/21 UBS BioNTech price target raised to $300 from $111 at UBS 08/20/21 Canaccord BioNTech price target raised to $450 from $240 at Canaccord PFE MRNA BNTX PFE Pfizer $43.89 / -0.57 (-1.28%) 07/28/21 Pfizer raises FY21 adjusted EPS view to $3.95-$4.05 from $3.55-$3.65 07/28/21 Pfizer reports Q2 adjusted EPS $1.07, consensus 96c 07/27/21 Notable companies reporting before tomorrow's open MRNA Moderna $429.30 / -11.54 (-2.62%) 08/05/21 Moderna reports Q2 EPS $6.46, consensus $6.04 08/04/21 Notable companies reporting before tomorrow's open 05/06/21 Moderna reports Q1 EPS $2.84, consensus $2.39 BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/09/21 BioNTech sees 2021 capex EUR 175M - EUR 225M 08/09/21 BioNTech reports Q2 EPS EUR 10.77 vs. (EUR 0.38) last year 05/10/21 BioNTech reports Q1 EPS EUR 4.39 vs. (EUR 0.24) last year PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel plans earlier than scheduled vote on Pfizer booster, Bloomberg says 09/17/21 U.S. buying hundreds of millions more Pfizer vaccine to donate, WaPo reports 09/17/21 FDA panel to review data on Covid booster shots, WSJ reports 09/16/21 Moderna's Hoge tells CNBC Delta variant has exposed vaccine weaknesses MRNA Moderna $429.30 / -11.54 (-2.62%) 09/13/21 Pfizer shot could be authorized for children age 5-11 in October, Reuters report 09/09/21 Biden to ask Labor Department for employer vaccine rule, NBC reports PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/16/21 Wall Street in Fives - Must Read Lists for Thursday 09/16/21 Wall Street in Fives - Must Read Lists at Midday 09/15/21 Wall Street in Fives - Must Read Lists for Wednesday 09/15/21 Wall Street in Fives - Must Read Lists at Midday MRNA Moderna $429.30 / -11.54 (-2.62%) 09/15/21 Fly Intel: After-Hours Movers 09/09/21 Wall Street in Fives - Must Read Lists for Thursday 09/27/21 Global Healthcare Virtual Conference 11/09/21 BioNTech - BNTX 09/17/21 Vaccines and Related Biological Products Advisory Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 05/06/22 PDUFA Date for MYFEMBREE 09/24/21 Pfizer PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/14/21 Pfizer put buyer realizes 95% same-day gains 08/24/21 Notable open interest changes for August 24th 08/23/21 Unusually active option classes on open August 23rd 08/19/21 Notable open interest changes for August 19th MRNA Moderna $429.30 / -11.54 (-2.62%) 09/16/21 Early notable gainers among liquid option names on September 16th 09/09/21 Early notable gainers among liquid option names on September 9th 08/31/21 Early notable gainers among liquid option names on August 31st 08/25/21 Early notable gainers among liquid option names on August 25th
Hot Stocks	FDA panel votes in favor of recommending Pfizer booster for people aged 65+ » 16:25 09/17/21 09/17 16:25 09/17/21 16:25 PFE Pfizer $43.89 / -0.57 (-1.28%) , MRNA Moderna $429.30 / -11.54 (-2.62%) , BNTX BioNTech $358.75 / -13.75 (-3.69%) An FDA advisory committee… An FDA advisory committee panel voted 18 "yes" to 0 "yes" on whether the safety and effectiveness data from clinical trial C4591001 support approval of a COMIRNATY booster dose administered at least six months after completion of the primary series for use in individuals 65 year or older and those at high risk of severe COVID-19. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Pfizer, Moderna lower after panel votes on booster recommendation 09/17/21 FDA panel votes against recommending booster dose of Pfizer COVID vaccine 09/16/21 Pfizer-BioNTech's Comirnaty gets full Health Canada approval for 12 and older 09/16/21 Pfizer CEO says time from vaccination seen a likely factor in breakthrough cases MRNA Moderna $429.30 / -11.54 (-2.62%) 09/16/21 Moderna says Canada approves Covid vaccine for ages 12 and older 09/15/21 Moderna says data support benefit of mRNA-1273 booster dose PFE MRNA BNTX PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 Evercore ISI Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters 09/16/21 Canaccord Exact Sciences salesforce expansion a net positive, says Canaccord 09/16/21 BofA Moderna boosters already reflected in 'bullish' consensus, says BofA 09/15/21 Raymond James Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James MRNA Moderna $429.30 / -11.54 (-2.62%) 08/12/21 Wells Fargo Wells says Moderna vaccine looks more effective than Pfizer's against Delta 08/06/21 Fly Intel: Top five analyst downgrades BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/27/21 UBS BioNTech price target raised to $300 from $111 at UBS 08/20/21 Canaccord BioNTech price target raised to $450 from $240 at Canaccord PFE MRNA BNTX PFE Pfizer $43.89 / -0.57 (-1.28%) 07/28/21 Pfizer raises FY21 adjusted EPS view to $3.95-$4.05 from $3.55-$3.65 07/28/21 Pfizer reports Q2 adjusted EPS $1.07, consensus 96c 07/27/21 Notable companies reporting before tomorrow's open MRNA Moderna $429.30 / -11.54 (-2.62%) 08/05/21 Moderna reports Q2 EPS $6.46, consensus $6.04 08/04/21 Notable companies reporting before tomorrow's open 05/06/21 Moderna reports Q1 EPS $2.84, consensus $2.39 BNTX BioNTech $358.75 / -13.75 (-3.69%) 08/09/21 BioNTech sees 2021 capex EUR 175M - EUR 225M 08/09/21 BioNTech reports Q2 EPS EUR 10.77 vs. (EUR 0.38) last year 05/10/21 BioNTech reports Q1 EPS EUR 4.39 vs. (EUR 0.24) last year PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/17/21 FDA panel plans earlier than scheduled vote on Pfizer booster, Bloomberg says 09/17/21 U.S. buying hundreds of millions more Pfizer vaccine to donate, WaPo reports 09/17/21 FDA panel to review data on Covid booster shots, WSJ reports 09/16/21 Moderna's Hoge tells CNBC Delta variant has exposed vaccine weaknesses MRNA Moderna $429.30 / -11.54 (-2.62%) 09/13/21 Pfizer shot could be authorized for children age 5-11 in October, Reuters report 09/09/21 Biden to ask Labor Department for employer vaccine rule, NBC reports PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/16/21 Wall Street in Fives - Must Read Lists for Thursday 09/16/21 Wall Street in Fives - Must Read Lists at Midday 09/15/21 Wall Street in Fives - Must Read Lists for Wednesday 09/15/21 Wall Street in Fives - Must Read Lists at Midday MRNA Moderna $429.30 / -11.54 (-2.62%) 09/15/21 Fly Intel: After-Hours Movers 09/09/21 Wall Street in Fives - Must Read Lists for Thursday 09/27/21 Global Healthcare Virtual Conference 11/09/21 BioNTech - BNTX 09/17/21 Vaccines and Related Biological Products Advisory Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 05/06/22 PDUFA Date for MYFEMBREE 09/24/21 Pfizer PFE MRNA PFE Pfizer $43.89 / -0.57 (-1.28%) 09/14/21 Pfizer put buyer realizes 95% same-day gains 08/24/21 Notable open interest changes for August 24th 08/23/21 Unusually active option classes on open August 23rd 08/19/21 Notable open interest changes for August 19th MRNA Moderna $429.30 / -11.54 (-2.62%) 09/16/21 Early notable gainers among liquid option names on September 16th 09/09/21 Early notable gainers among liquid option names on September 9th 08/31/21 Early notable gainers among liquid option names on August 31st 08/25/21 Early notable gainers among liquid option names on August 25th
Hot Stocks	Exelixis announces FDA approval of CABOMETYX » 16:24 09/17/21 09/17 16:24 09/17/21 16:24 EXEL Exelixis $20.74 / +0.205 (+1.00%) Exelixis announced that… Exelixis announced that the U.S. FDA approved CABOMETYX for the treatment of adult and pediatric patients 12 years of age and older with locally advanced or metastatic differentiated thyroid cancer that has progressed following prior vascular endothelial growth factor receptor-targeted therapy and who are radioactive iodine-refractory or ineligible. The FDA granted Breakthrough Therapy designation and Priority Review to CABOMETYX and its approval comes more than two months ahead of the Prescription Drug User Fee Act target action date of December 4, 2021. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EXEL Exelixis $20.74 / +0.205 (+1.00%) 09/07/21 Exelixis announces passing of Chief Medical Officer Gisela Schwab 08/25/21 Exelixis partner Takeda and Ono get Japan approval for cabozantinib in RCC 08/16/21 Exelixis, Invenra expand discovery and licensing collaboration by 20 targets 08/05/21 Exelixis announces FDA acceptance of Cabometyx sNDA EXEL Exelixis $20.74 / +0.205 (+1.00%) 08/06/21 H.C. Wainwright Exelixis price target raised to $64 from $35 at H.C. Wainwright 06/29/21 H.C. Wainwright Exelixis price target lowered to $35 from $47 at H.C. Wainwright 06/29/21 Oppenheimer Exelixis price target lowered to $27 from $35 at Oppenheimer 06/28/21 Piper Sandler Exelixis selloff on trial miss an overreaction, says Piper Sandler EXEL Exelixis $20.74 / +0.205 (+1.00%) 08/05/21 Exelixis sees FY21 revenue $1.3B-$1.4B, consensus $1.23B 08/05/21 Exelixis reports Q2 adjusted EPS 37c, consensus 7c 05/06/21 Exelixis reports Q1 EPS 9c, consensus 3c EXEL Exelixis $20.74 / +0.205 (+1.00%) 06/28/21 Fly Intel: Pre-market Movers 06/14/21 Fly Intel: Pre-market Movers 09/27/21 Global Healthcare Virtual Conference 12/04/21 PDUFA Date for Cabometyx (Cabozantinib)

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

PDUFA Date for BRUKINSA (Zanubrutinib) in MZL Government Event
Tomorrow at 00:00

ESMO 2021 Virtual Congress Conferences

Virtual Conference
Tomorrow at 00:00

Digital Entertainment/Digital Marketing Virtual Bus Tour Conferences

Virtual Bus Tour
ADRNY ...
Tomorrow at 00:00

GroceryShop Conferences

Mandalay Bay Convention Center, Las Vegas, NV
MESO
2021-09-20 at 00:00

Mesoblast - MESO Conference Calls
ETSY
2021-09-20 at 00:00

Etsy - ETSY Conference Calls
2021-09-20 at 00:00

GroceryShop Conferences

Mandalay Bay Convention Center, Las Vegas, NV
2021-09-20 at 00:00

Solar Power International: Smart Energy Week Conferences

CANCELLED
2021-09-20 at 00:00

REITworks: 2021 Virtual Conference Conferences

Virtual Conference
INFI ...
2021-09-20 at 00:00

Fall Healthcare Life Sciences & MedTech Summit Conferences

Virtual Summit

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SRAD X SRAD Sportradar IPO Managers: JPMorgan, Morgan Stanley, Citi & UBS, BofA, Deutsche Bank, Jefferies, Canaccord Priced at: $27.00 19M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVTR X AVTR Avantor Secondary Managers: Goldman Sachs, Citi & BofA Priced at: $42.00 20.83M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NGMS X NGMS Neogames Secondary Managers: JPMorgan, Deutsche Bank, BofA, Macquarie, Truist & Stifel Priced at: $36.00 3.46M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LSI X LSI Life Storage Spot Secondary Managers: Citi & Wells Fargo Priced at: $122.40 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MP X MP MP Materials Spot Secondary Managers: Morgan Stanley Priced at: $35.00 4.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OPEN X OPEN Opendoor Technologies Spot Secondary Managers: Citi Priced at: $16.90 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRPX X VRPX Virpax Pharmaceuticals Spot Secondary Managers: ThinkEquity Priced at: $6.00 3.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	CPNG X CPNG Coupang Block Trade Managers: JPMorgan Priced at: $29.85 57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WMS X WMS Advanced Drainage Block Trade Managers: Morgan Stanley Priced at: $110.35 1.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BROS X BROS Dutch Bros IPO Managers: BofA, JPMorgan & Jefferies, Barclays, Piper Sandler, Baird, William Blair, Cowen, Stifel, AmeriVet, Penserra, SEEL, Tribal Priced at: $23.00 21M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DH X DH Definitive Healthcare IPO Managers: Goldman Sachs & JPMorgan, Morgan Stanley, Barclays, Credit Suisse, Deutsche Bank, Canaccord, Raymond James, Stifel, Drexel Hamilton, Loop Capital Priced at: $27.00 15.556M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DICE X DICE Dice Holdings IPO Managers: BofA, SVB Leerink & Evercore ISI Priced at: $17.00 12M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EZFL X EZFL EzFill IPO Managers: ThinkEquity Priced at: $4.00 6.25M Shares KTTA X KTTA Pasithea IPO Managers: EF Hutton Priced at: $5.00 4.8M Shares ONON X ONON On Holding IPO Managers: Goldman Sachs, Morgan Stanley & JPMorgan, Allen & Co., UBS, Credit Suisse, Baird, Stifel, Telsey Advisory Priced at: $24.00 31.1M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PRCT X PRCT Procept BioRobotics IPO Managers: BofA & Goldman Sachs, Cowen, Guggenheim, SVB Leerink Priced at: $25.00 6.56M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TWKS X TWKS Thoughtworks IPO Managers: Goldman Sachs & JPMorgan, Credit Suisse, BofA, Citi, RBC Capital, HSBC, Baird, Cowen, NMRA, Piper Sandler, Wedbush, William Blair, COAK, SIEB Priced at: $21.00 36.842M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TYRA X TYRA Tyra Biosciences IPO Managers: BofA, Jefferies & Cowen Priced at: $16.00 10.8M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APG X APG APi Group Secondary Managers: JPMorgan, RBC Capital, BofA, Baird & UBS, BTIG Priced at: $20.25 19.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASO X ASO Academy Sports Secondary Managers: Credit Suisse, KKR, JPMorgan & BofA Priced at: $44.75 18.645M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BRP X BRP BRP Group Secondary Managers: JPMorgan, Wells Fargo, BofA, Morgan Stanley, Jefferies & William Blair, Keefe Bruyette, Raymond James, Capital One, Dowling Priced at: $30.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAW X LAW CS Disco Secondary Managers: JPMorgan & BofA Priced at: $53.00 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LESL X LESL Leslie's Secondary Managers: Morgan Stanley, Goldman Sachs & BofA, Jefferies, Wolfe Research, Nomura, Baird, Guggenheim, Piper Sandler, Stifel, William Blair, Telsey Advisory, Loop Capital, Ramirez, AMVT Priced at: $22.00 15.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAR X PAR Par Technology Secondary Managers: Goldman Sachs, BTIG, Needham, Craig-Hallum Priced at: $56.00 893K Shares AVTX X AVTX Avalo Therapeutics Spot Secondary Managers: Jefferies & RBC Capital Priced at: $2.20 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Spot Secondary Managers: Jefferies Priced at: $5.75 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HUT X HUT Hut 8 Mining Spot Secondary Managers: Canaccord Priced at: $8.55 17.55M Shares LYV X LYV Live Nation Spot Secondary Managers: Goldman Sachs Priced at: $86.90 5.23M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUWE X NUWE Nuwellis Spot Secondary Managers: Ladenburg Priced at: $2.50 3.483M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ACT X ACT Enact Holdings IPO Managers: Goldman Sachs & JPMorgan Priced at: $19.00 13.31M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FORG X FORG ForgeRock IPO Managers: Morgan Stanley & JPMorgan, Deutsche Bank, MIZU, BTIG, Cowen, Piper Sandler, Truist, William Blair Priced at: $25.00 11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ELY X ELY Callaway Golf Secondary Managers: Goldman Sachs, BofA & JPMorgan, MUFG Priced at: $29.25 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FIGS X FIGS Figs Secondary Managers: Goldman Sachs, Morgan Stanley, Barclays & Credit Suisse, BofA, Cowen, Guggenheim, KeyBanc, Oppenheimer, Piper Sandler, Telsey Advisory, ACAD, SEEL, Ramirez, SIEB Priced at: $40.25 8.92M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MCB X MCB Metropolitan Bank Secondary Managers: JPMorgan & Keefe Bruyette Priced at: $75.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LIFE X LIFE aTyr Pharma Spot Secondary Managers: Piper Sandler & RBC Capital Priced at: $8.00 9.38M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Only 10% plan to upgrade to Apple's new 5G iPhone, Piper survey shows

TODAY'S FREE FLY STORIES

Get Full Fly Access